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SUMMARY
Inherited glomerular properties have been investigated in two strains 
of rat chosen because one of them, Lewis is susceptible to Heymann 
nephritis whereas the other DA, is resistant. The glomerular 
properties examined were the charge on the glomerular basement 
membrane (GBM) and the mesangial uptake of circulating proteins. The 
former was studied by measuring the specific renal uptake of cationic 
IgG which was significantly less in Lewis rats. The deposition of 
cationic IgG on the GBM was significantly less in Lewis rats. The 
deposition of cationic IgG on the GBM 15 minutes after its 
administration, as judged by immunofluorescent studies, confirmed this 
finding. Interestingly, the specific hepatic and splenic uptake of 
cationic IgG at 15 minutes and the binding of Alcian blue (a cationic 
dye) to red cells, were all less in Lewis rats than DA rats.
Therefore, the negative charge on all the cell and membrane surfaces 
examined was less in Lewis rats than DA rats. The second glomerular 
property, the mesangial uptake of circulating proteins, was studied by 
measuring the renal uptake of aggregated IgG. This was greater in DA 
rats than Lewis rats.
The effect of these differences in glomerular properties in the 
expression of some animal models of glomerular disease was 
investigated. Lewis rats developed proteinuria following infusion of 
hexadimethrine, a polycation, into the renal artery whereas DA rats 
did not. This confirmed the functional significance of the measured 
difference in GBM charge between the two strains. On the other hand,
DA rats developed more proteinuria following puromycin aminonucleoside 
which may have been due to greater mesangial uptake of the drug. The 
differences in susceptibility to Heymann nephritis in the Lewis strain
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was confirmed. Chronic serum sickness induced by cationic HSA led to 
capillary loop deposits in Lewis rats whereas DA rats had mesangial 
deposits even in control kidneys. Therefore, Lewis rats have lesser 
membrane and cell surface charge, a lower mesangial uptake of 
circulating proteins than DA rats and are more liable to develop 
proteinuria and capillary loop deposits. The clinical relevance of 
these findings was tested by examining the red cell charge of three 
groups of patients with idiopathic membranous glomerulopathy (IMN), 
minimal change nephropathy (MCN) and IgA nephropathy (IgAN) who were 
in clinical remission or who had proteinuria less than 2.2g/24 hours. 
MCN and IMN are associated with heavy proteinuria which rarely occurs 
in IgAN. IMN is associated with capillary loop deposits whereas IgAN 
is associated with mesangial deposits. The red cell charge was 
significantly greater in patients with IgAN than MCN or IMN but all 
three patient groups fell within the normal range. If red cell charge 
correlates with GBM charge in patients as it does in the two strains 
of rats, the similarities between the kidneys of patients with IMN and 
Lewis rats and between the kidneys of patients with IgAN and DA rats 
are striking.
Prostaglandins and their precursors have been shown to have beneficial 
effects on human and animal glomerulopathies. Modulation of mesangial 
uptake by prostaglandins and their precursors was investigated.
Release of prostacyclin by the aortas of Lewis rats was greater than 
the aortas of DA rats. Studies of the effect of prostanoids or 
mesangial uptake of circulating antigen (cationic IgG) showed that 
all polyunsaturated fatty acid diets and infusions of prostacyclin 
(PGI^) or PGE^ caused an increase in both strains of rats whatever 
the effect on the uptake by the whole kidney. No difference between 
the two strains was observed. This may have been due to increased
14
glomerular production of angiotensin II which is known to increase 
mesangial uptake. Prostaglandins and precursors have been shown to 
increase mesangial uptake of antigen. Modulation of mesangial uptake 
by prostaglandins may offer a new approach to therapy of these 
nephropathies.
The results of these studies show that the glomerulus is not simply a 
passive participant of systemic events but that its properties vary 
within strains and are important and previously unrecognised factors 
in the individual response to various forms of glomerular injury.
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CHAPTER I
RENAL ANATOMY AND PHYSIOLOGY OF THE KIDNEY 
1;1:1 Introduction
The kidneys are paired organs which lie retroperitoneally on the 
posterior abdominal wall. They are bean shaped with a hilum at the mid 
point of the medial aspect. Each kidney measures 12 x 7 x 3cm but 
there is considerable variation from person to person. In the adult 
male they weigh 150-170g each and slightly less in the female. At the 
hilum the renal artery and vein and the renal pelvis join the organ.
The whole kidney is covered by a thin fibrous capsule which is joined 
at the hilus to the artery, vein and pelvis (1).
The kidney is made up of cortex and medulla which are sharply 
demarcated on the cut surface where the pyramids are situated (Fig 1).
The pyramid is that portion of the medulla which projects towards the 
pelvis, the distal part being called the papilla. The cortex extends 
into the space between the pyramids as the columns of Bertin. Faint 
striations are visible on the cortex running in the direction of the 
hilum. These are medullary rays which contain collecting tubules and 
ascending limbs. The cortex contains glomeruli with proximal and 
distal convoluted tubules and the medulla contains all the remaining 
constituents of the nephron.
1:1:2 Structure of the Kidney
The functional unit of the kidney is the nephron, an expression first 
coined by Braus (2). Each human kidney has been estimated to contain 
about 1,200,000 nephrons. This contrasts with approximately 
30,000-34,000 nephrons in each adult rat kidney (3). The essential
MEDULLA
CORTEX
PAPILLA
FIG 1
ARCUATE
ARTERY
INTERLOBAR
ARTERY
RENAL
ARTERY
PELVIS
HILUS
URETER
The gross structure of the cut surface of a kidney.
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components of the nephron are the renal glomerulus, the proximal 
tubule, the loop of Henle, the distal tubule and the connecting 
segment. The nephron is a thin tube approximately 50mm long beginning 
at the glomerulus and ending where it joins a collecting duct. The 
upper end lies in the cortex where it is invaginated by a mesh of 
capillaries - the glomerulus. The next portion of the nephron is a 
coiled tube called the proximal tubule which passes medially into the 
medulla towards the hilum. There is a U-shaped bend in the medulla 
and the nephron then runs towards the cortex. The portion in the 
medulla is called the loop of Henle. The final portion in the cortex 
is the distal tube and, like the proximal tubule, it is coiled. At 
the end of the distal tubule the nephron straightens out, passes 
medially and joins a collecting duct in the medulla. Several 
collecting ducts join to form the collecting ducts of Bellini which 
open directly on the surface of the papillae. A simplified schematic 
representation of a nephron is shown in Fig 2.
1:1:3 Structure and function of the glomerulus
The glomerular tuft is made up of a coil of specialized capillaries 
fed by an afferent and drained by an efferent arteriole. The tuft 
lies in a space the boundary of which is called the glomerular capsule 
or Bowman’s capsule. The capsule is spherical and has an opening 
directly into the proximal convoluted tubule. The glomerular tuft and 
glomerular capsule have a continuous lining of epithelial cells which 
are in direct continuity with those lining the proximal tubules (4).
The function of the renal glomerulus is to filter the blood, producing 
a protein free filtrate of the blood plasma, while retaining the 
cellular elements of the blood and the plasma proteins in the
Distal
convoluted
tubule
Proximal
convoluted
tubule
Afferent 
and efferent 
arterioles
GLOMERULUS
Thick
segment Loop of 
Henle
Thin
segment
Collecting
duct
FIG 2 Diagram of a nephron.
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circulation (5). It is at the level of the capillaries that 
filtration takes place. To carry out this function the structure of 
the glomerular capillaries are highly specialized. They are divided 
into peripheral regions which are believed to constitute the main 
filtration surface and axial regions buried deeper in the glomerular 
tuft. The glomerular capillary wall is considered to be constructed 
of four components - three cell types, endothelial, epithelial and 
mesangial cells and the extracellular basement membrane (Fig 3).
1 :1 ;4 The glomerular basement membrane clearance studies
Renal clearance studies of macromolecules with a wide variety of sizes 
and charges suggested that charge as well as size, played a 
fundamental role in the transfer of macromolecules across the GBM 
Bohrer and Co-workers (1978) showed that there was a decreased 
fractional clearance of anionic dextran sulphate and an increased 
clearance of diethylaminoethyl dextran (DEAE) when compared with 
neutral dextran (8). Rennke and Venkatachalam (1977), using ferritin 
molecules with variable isoelectric points (pi) showed that as the net 
negative anionic charge increased penetration into the capillary wall 
was restricted (9.'). Conversely, cationic ferritin molecules 
penetrated regularly through the entire GBM up to the epithelial slit 
pore. Kelly and Cavallo (1977) showed that as proteinuria occurs and 
increases in NZB/NZW mice, the localization of native (anionic) 
ferritin extends across the GBM into the urinary space (10). Kuhn et 
al (1977) studied the glomerular clearance of endogenous albumin and 
ferritin in nephrotoxic nephritis and have shown moderate passage of 
these tracers, especially in areas where loss of epithelial attachment 
to GBM had occurred (It).
Charge modulates permeability in both healthy and experimentally
FIG 3 - SCHEMATIC DIAGRAM OF GLOMERULAR LOBULE (6)
■*50 nm 1
? CP c: Bndof helium 
Lomino roro inferno 1 
Lamina densa
Lamina roro exferno
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injured glomeruli but the location of the major charge barrier was 
uncertain. The epithelial glomerular polyanion was thought to be the 
primary anionic site, but evidence derived from the ultrastructural 
studies of cationic probes has led to a reappraisal of this first 
hypothesis.
Ultrastructural tracer studies
The nature and site of the glomerular permeability barrier still is an 
area of controversy. The earliest studies using electron dense 
tracers suggested that the barrier was primarily at the level of the 
GBM. In 1961 Farquhar and colleagues showed that ferritin readily 
traversed the endothelial fenestrae but did not penetrate to any 
extent beyond the lamina densa (12). They concluded that the GBM , 
particularly the lamina densa was the main filtration barrier, and 
that the epithelial cells played a monitoring role by controlling the 
entry into the urinary space of those molecules which had escaped the 
barrier. Using enzyme tracers many groups of workers concluded that 
the final barrier for macromolecules was at the level of the 
filtration slit, and that its' diaphragm was important in these 
regards (13).
On the basis of the then available evidence, Karnovsky and colleagues
proposed the double barrier or filter hypothesis that:
(1 ) The GBM restricts the passage of protein over a wide range 
of molecular size.
(2) The slit pore, or slit diaphragm, functions as an additional
barrier for relatively smaller molecules that were incompletely 
restricted by the GBM (14,15).
This hypothesis, however, was based solely on size discrimination when
this was considered to be the main determinant of glomerular
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filtration.
Venkatachalam noted the behaviour of two relatively large molecules, 
myleperoxidase and catalase. Myleoperoxidase rapidly traversed the 
GBM whereas catalase (in contrast to myeloperoxidase) crossed slowly.
He postulated that these differences might be ascribed to variations 
in molecular charge, the isolectric point of myleoperoxidase being 
greater than 10 compared to 5.7 for catalase (16).
Studies by Caulfield and Farquhar using neutral dextrans showed that 
restriction of the tracer molecule was not at the slit pore but at the 
level of the GBM and concluded once again that the GBM represents the 
primary barrier to the filtration of macromolecules (17). Chang et al 
and Rennke et al reported the physiologic studies detailing the 
importance of the effect of molecular charge on glomerular 
permeability to macromolecules. While anionic ferritin was 
completely excluded from the GBM cationic ferritin penetrated the GBM 
in greatly increased amount (18,19).
Nature and location of anionic sites in glomeruli
After determining by clearance studies that the glomerulus has both 
size and charge selective properties attention shifted to 
investigating which glomerular component(s) was responsible for 
establishing the charge barrier function of the glomerulus. This was 
a matter of considerable importance because loss of the charge barrier 
function has been found in several experimental diseases characterized 
by proteinuria, which are used as models for human diseases (20).
Cationic stains such as colloidal iron and alcian blue have been used 
to demonstrate the anionic sites. Using these stains, negatively
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charged groups were shown to be present in all the layers of the 
capillary wall (ie) in the GBM and on the surfaces of endothelial and 
epithelial cells. The thick sialic rich, cell surface coat of the 
epithelium, captured the attention of a number of workers (21). This 
membrane, however, is on the wrong side of the GBM to produce its 
charge selective properties (22 ). However, it has been shown to be 
essential for the maintenance of the normal arrangement of foot 
processes and their slit pores. Neutralization of the coat by 
perfusion with polycations disrupts the arrangement of the foot 
processes and reperfusion with polyanion restores them to their normal 
state (23).
Various other probes were used as . stains to detect anionic sites in 
the GBM and to determine where the greatest concentration of 
negatively charged groups occured. Lyzozyme (MW 14,000) because of 
its hi^ isoelectric point (pi 11.0) bound to anionic sites in the GBM 
and in effect acted as a stain for anionic groups. Using this method 
Caulfield et al found anionic sites in all layers of the basement 
membrane (24). Further studies showed that a network of negative 
sites were concentrated in the laminae rarae. Cationized ferritin 
bound to sites within the laminae rarae but not the lamina densa or 
epithelial cell surface, thereby demonstrating that the sites with the 
highest density charge or concentration of negatively charged group in 
the glomerulus correspond to the sites where the heparan sulphate 
proteoglycans are located in the laminae rarae (25).
Role of gly^ceaminoglycans in the permeability 
of the GBM to macromolecules
Glycosaminoglycans are polysaccharides that are found in tissues of 
vertebrates usually in covalent assocation with protein. Seven types
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are commonly recognised, six of these are structurally related, with a 
carbohydrate back-bone consisting of alternating uronic acid 
(L iduronic adid and/or D - glucuronic acid) and hexosamine 
(D - glucosamine or D - galactosamine) residues. All except one, 
hyaluronate, are sulphated. The glycoaminoglycans are widely- 
distributed within the animal kingdom and are commonly distinguished 
in vertebrate tissues. They are all polyanions that have acidic 
sulphate and/or carboxyl groups (25).
As the glycoaminoglycan variety of proteoglycans are among the most 
highly negatively charged molecules known, it was assumed that GAG 
might be one of the GBM components responsible for endowing the GBM 
with its properties as a charge selective filter. Direct evidence for 
this assumption was provided by the following experiments. Perfusion 
of the whole kidney by GAG degrading enzymes in situ, led to marked 
changes in the permeability of the GBM with increasing clearance of 
Bovine serum albumin (BSA MW 65,000) and anionic ferritin (MW 480,000) 
(28,29). Removal of all GAG (including heparan sulphate) by digestion 
with hepar.'ioiase, led to increased leakage of both ferritin (MW 
480,000) and BSA (MW 65,000) into the urinary spaces. Removal of 
hyaluronic acid alone by digestion with streptomyces hyaluronidase or 
removal of most GAG’s but not heparan sulphate with chrondroitinase 
led to increased clearance of BSA but not ferritin (27,28). These 
findings suggested that both heparan sulphate and hyaluronic acid may 
play a role in maintaining the charge selective filter properties of 
the GBM.
However, it is still not clear if alterations in GAG are responsible 
for the loss of charge selectivity found in some glomerular diseases. 
Previous workers have reported reduced binding of cationic probes in 
anionic sites in the laminae rarae in experimental animals
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with glomerular diseases associated with proteinuria (29). The 
proposed structure for the GBM can be seen in Fig 5 (30).
1 :1 :5 THE MESANGIUM 
Structure
The glomerular mesangial cells reside in an intercapillary position in 
the centre of several capillary loops (31 ) Fig 4. Zimmerman 
utilizing light microscope techniques provided an excellent 
description of the mesangial region as early as 1933 (32). Decisive 
proof for the existence of a third glomerular cell, distinctive from 
the endothelium and epithelium, resulted from electron microscope 
observations of the kidney. The studies by Farquhar et al and Latta 
et al clearly demonstrated that these cells actively phagocytosed 
electron dense tracers and were functionally distinct from glomerular 
endothelial cells (33,34,35).
Mesangial cells are quite irregular in shape, contain an indented 
nucleus and have numerous elongated cytoplasmic processes extending 
from the main body of the cell (36). The nucleus is much denser than 
that of adjacent endothelial cells, a feature that permits 
identification of mesangial cells even at the light microscopic level. 
There is evidence from recent studies that at least some of the 
phagocytic cells in the mesangium of the rat kidney constitute a 
functionally distinct population of mesangial cells bearing 
I-region-associated antigens (la)(37,38). However, the predominant 
cell in the mesangium is a non-phagocytic, la negative cell that 
resembles a smooth muscle cell which contracts when stimulated by
f/
EPITHELIAL CELL 
MESANGIAL CELL
FIG 4 - A CROSS SECTION OF A GLOMERULAR LOBULE 
DEMONSTRATING THE RELATIONSHIP BETWEEN 
THE ENDOTHELIAL, EPITHELIAL AND MESANGIAL 
CELLS (7)
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FIG 5 - SCHEMATIC REPRESENTATION OF THE PROPOSED
SUPRAMOLECULAR ORGANISATION OF THE GLOMERULAR 
BASEMENT MEMBRANE (30)
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angiotensin II and arginine vasopressin (39). The cell is capable of 
synthesising collagen types I,II and IV in vitro and lacks Fc or C3 
receptors. The function of this cell is probably to regulate flow 
through the glomerular capillaries' under the influence of hormones 
particularly angiotension II produced locally within the glomerulus. 
The intracapillary position of the mesangium has made it relatively 
inaccessible to study either in the intact animal or in vitro. Harper 
et al have devised a technique in which isolation of pure, homogeneous 
cultures of rat glomerular cells is possible (40). One cell type was 
polygonal, forms domes in culture, has cilia and stains predominantly 
and diffusely with the anti-platelet myosin antibody. The other cell 
type was spindle-shaped, had numerous filaments and stained along its 
filaments with anti myosin antibody from both muscle and non muscle 
sources. Since the first set of characteristics was common to 
epithelial cells and the latter to smooth muscle cells, isolation of 
glomerular epithelial and mesangial cells was thought to have been 
achieved. The glomerular capillary loop is almost encircled by the 
GBM except in an area overlying the mesangium, where only the 
fenestrated endothelial cell processes separate the mesangial matrix 
from the blood in the capillary. All circulating molecules with no 
restriction due to size, enter the mesangium and are thought to flow 
towards the hilum where they disappear (41).
Function
The exact functions of the mesangium are poorly defined but there is 
evidence to suggest that it has an important role in keeping the 
glomerular basement membrane free of macromolecular debris (42,43). 
Their probable role as supportive elements of the mesangium of the 
glomerular tuft has been suggested.
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Mesangial cells possess contractile as well as phagocytic capabilities 
(44). Experimental studies involving the intravenous injection of 
ferritin (35) thorotrast (33,44), colloidal carbon (44,45) and 
aggregated proteins (46,47) have demonstrated the uptake of the tracer 
material by the mesangium. Factors such as blood level, 
physiochemical characteristics and haemodynamic factors influence 
mesangial uptake (48). Once in the mesangial area, complexes can 
either pass back into the blood, be phagocytosed and broken down by 
resident phagocytes or pass down the mesangial channel towards the 
glomerular stalk (49). The precise route by which these complexes 
leave the glomerulus is unknown although they appear to pass close to 
the juxtaglomerular apparatus.
Many substances accumulate within the mesangial region; some persist 
while others are relatively rapidly eliminated. An example of the 
latter is heat aggregated IgG (49) which disappears from the mesangium 
within days whereas carbon particles (45,51) or ferritin protein 
conjugates (50) can persist for months. Evidence suggests that 
molecular size and charge influence the degree of uptake and 
persistence of macromolecules with the mesangium (51,52).
Batsford et al using ferritin isomers showed that molecular size was 
found to be a major determinant of the extent and rapidity of antigen 
uptake, but had only minor influence on persistence. The rapidity of 
uptake and antigen persistence was charge dependent, but to a limited 
extent. Biologic (toxic) activity of macromolecules appears to be a 
very important determinant of mesangial handling since glutaraldehyde- 
treated ferritin was taken up much more rapidly and to a greater 
extent than native ferritin and could persist for very prolonged 
periods (53). The fate of the antigenic material within the 
glomerulus has pathogenic relevance since not only would its mere
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presence interfere with the clearing function but it could act as 
planted target antigen for circulating antibody leading to in situ 
immune complex formation.
The mesangium in human diseases
That injury to the glomerulus might impair macromolecular traffic 
through the mesangium is suggested by studies on rats with long 
standing nephrotic syndrome and focal sclerosis induced by repeated 
injections of puromycin aminonucleoside (54,55). Aggregated Igl 
administered to these animals persisted for prolonged periods of time 
within the glomeruli,which suggested that the mesangial clearing 
mechanisms were impaired.
There are numerous diseases in man in which pathological changes are 
limited or predominantly involve the mesangium in which the above 
process might be involved. Diseases such as anaphylactoid purpura, 
mesangial IgA, mesangiocapillary glomerulonephritis, mesangial lupus 
and diabetic nephritis have many common features including focal or 
diffuse mesangial cell proliferation, deposition of IgA along with 
other immunoglobulin and complement components in the mesangium (56). 
However, the exact pathogenesis of these lesions remains obscure.
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1 :1 :6 Renal prostaglandins
Prostaglandins are synthetised from 20 carbon polyunsaturated acids 
containing three, four or five double bonds (57). These fatty acids 
are contained in the phospholipids of cell membranes phospholipids of 
all tissues. In man the main precursor of prostaglandins is 
arachidonic acid (AA) which in response to many different stimuli 
(58), is released from the phospholipids of cell membranes and rapidly 
metabolised into oxygenated products including prostaglandins and 
thromboxanes of the 2-series.
Prostaglandins and thromboxane are ubiquitous in mammalion tissue.
They subserve a host of actions involving regulation of smooth muscle 
tone, the blood coagulation cascade, hormone secretion, the 
inflammatory response, central nervous system function and fluid and 
electrolyte transport (59).
Interest in renal prostaglandins began with the description by Lee et 
al of a vascoactive acidic lipid in the rabbit renal medulla (60). 
Subsequent studies showed that the kidney contains all enzymes 
necessary for prostanoid and thromboxane synthesis, and that the 
generation of each of these products can be demonstrated in renal 
tissues (Table 1 ) (61).
Recent research has led to significant advances in the understanding 
of renal prostaglandin biochemistry and physiology. The physiological 
role of prostaglandins in modifying various renal functions has become 
increasingly apparent over the last years. At present there is 
convincing evidence that prostaglandins influence:-
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(1 ) Renal blood flow particularly following injury.
(2) Release of renin
(3) The urinary concentrating mechanism (61).
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SECTION 2
1 :2:1 Classfication of human glomerulonephritis
Disorders of glomerular structure and function constitute one of the 
major problems encountered in the practice of clinical nephrology. 
Beginning with Richard Bright in the 183O’s, the study of glomerular 
diseases has focused on the relationship of clinical findings to 
morbid anatomy (69). Samuel Wilks (1853) produced the first valid 
attempt to classify Bright's disease according to its clinical and 
pathological features (70). His special contribution was to recognise 
that the contracted granular kidney could arise as part of a general 
decay in which the systemic arterial system as a whole was intimately 
concerned. In 1914, Volhard and Fahr published their splendid 
illustrated monograph on Bright's disease illustrating all forms of 
the disease with a wealth of clinical, anatomical and histological 
detail. Their classification remains the foundation on which our 
present clinical and pathological conception of Bright's disease is 
built (71). However, this classification did not emphasise the two 
ways in which Bright's disease commonly presents; the acute form with 
haematuria, and the insidious form with oedema. As a result, Ellis 
(1942) proposed a new classification of nephritis which was 
essentially clinical in nature. To acute nephritis he gave the name 
Type 1 nephritis. To those cases of gradual onset and which presented 
with oedema he called them Type 11 nephritis (72).
Until comparatively recently these studies were largely based upon 
information derived from post mortem examination of the kidney. Thus, 
only a portion of the spectrum of glomerulopathic processes were 
uncovered, and a vast area of natural history remained uncharted.
This situation has improved considerably because of four developments.
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First, the increasing use of percutaneous kidney biopsy in diagnosis 
and in the management of patients (73). Second, improved histologic 
techniques and the application of electron microscopy revealed a 
number of previously unrecognised structural features. Third, the use 
of immunofluorescence made possible the identification of 
immunoglobulins and complement in various patterns within renal 
tissue. Lastly, laboratory experimentation served to develop models 
of immunologically mediated kidney disease.
A classification of glomerulonephritis is shown in Table 2. 
Glomerulonephritis of the first group are presumed, or known to be 
caused, by immunological mechanisms because immunoglobulins and 
complement can be demonstrated in glomerular structures. Glomerular 
diseases that are caused by antigen antibody complexes formed in the 
circulation and/or in situ are listed in subgroup 1 A.
Subgroup IB includes glomerular diseases caused by autoantibodies that 
react with native glomerular basement membrane (GBM) antigens.
Subgroup 1C lists membrano-proliferative glomerulonephritis Type II or 
dense deposit disease, in which there is a striking accumulation of 
C3, without significant amounts of immunoglobulins in glomerular 
structures. Subgroup ID, renal allograft rejection is a condition in 
which sensitised cells, transplantation antibodies and transplantation 
antigen/antibody complexes are instrumental in tissue damage ie, the 
host mounts an immunological assault on the transplanted kidney.
Lastly, group II consists of glomerular diseases in which there is no 
impressive evidence of pathogenetic immunological mechanisms. This 
assumption is based on the absence of immunoglobulins and complement 
in renal structures. However, this conclusion may be occasionally
TABLE 2
Classification of human glomerulonephritis
I. Diseases presumed or known to result from immunologic mechanisms
A. Immune complex glomerulonephritis
1. Diseases of known etiology
a) Poststreptococcal glomerulonephritis
b) Glomerulonephritis associated with other bacterial infections; 
staphylococcal; pneumococcal; bacterial endocarditis; 
atrioventricular shunt infections; visceral abscesses; 
secondary syphilis; leprosy.
c) Glomerulonephritis associated with viral infections: hepatitis 
B infection; dengue fever; mumps; varicella; subacute 
sclerosing panencephalitis; infectious mononucleosis.
d) Glomerulonephritis associated with protozoal infections: 
malaria; schistosomiasis; toxoplasmosis; kala-azar; filariasis.
2. Renal diseases associated with systemic diseases of unknown 
etiology
a) Lupus nephritis
b) Nephritis with anaphylactoid purpura
c) Nephritis in polyarteritis nodosa
d) Nephritis in idiopathic "mixed" cryoglobulinemia
3. Primary renal diseases of unknown etiology
a) Membranous glomerulonephritis
b) Membranoproliferative glomerulonephritis Type I
c) IgA-IgG glomerulonephritis; IgM glomerulonephritis
d) Some cases of rapidly progressive glomerulonephritis
e) Some cases classified as focal glomerulonephritis
f) Some cases classified as chronic sclerosing glomerulonephritis
g) Unclassified glomerulonephritis
B. Anti-glomerular basement membrane glomerulonephritis: some cases
of rapidly progressive glomerulonephritis and Goodpasture's syndrome
C. Diseases associated with local deposition of complement: 
Membranoproliferative glomerulonephritis Type II or basement 
membrane dense deposit disease?
D. Renal allograft rejection (multiple immunologic mechanisms)
II. Diseases without impressive evidence of immunologic mechanisms
A. Most cases of chronic sclerosing glomerulonephritis
B. Some cases of focal glomerulonephritis
C. Nephrotic syndrome with minimal glomerular lesions (Lipoid nephrosis)
D. Hemolytic-uremic syndrome and other coagulopathies
E. Diabetic nephropathy
F. Amyloidosis and dysproteinemias
G. Unclassified glomerular diseases
Although not generally classified as a form of glomerulonephritis, 
it is included here for convenience.
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erroneous especially in acute immune complex disease in which immune 
deposits may be scanty or may disappear before resolution of the 
lesions.
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SECTION 2
IMMUNE COMPLEX DISEASE
1:2:2 Circulating immune complexes
The importance of immune complex nephritis as a major 
immunopathogenetic mechanism in renal disease has been recognized for 
many years. The interaction of antigen and antibody sets in motion 
immunopathological processes that ultimately caused renal disease, 
particularly glomerulonephritis (74). The glomerular capillary, a 
sophisticated ultrafilter, seemed to be a prime target for immunologic 
injury. The understanding of this process has been greatly 
facilitated by immunofluorescence studies in which granular or 
irregular deposits of immunoglobulin and complement were found in 
renal structures in patterns that resemble those found in experimental 
models of immune complex nephritis.
In the glomeruli, three main types of immune complex nephritis can be 
distinguished in humans and experimental animal models. The deposits 
may be present predominantly on the epithelial side of the CBM 
(membranous glomerulonephritis): predominantly in the mesangium 
(IgA -IgC glomerulonephritis) or in the mesangium and between the 
endothelium and CBM (mesangiocapillary glomerulonephritis Type 1).
The mechanism responsible for the variation in the deposition of 
immune complexes were not fully known. In the late fifties, Cermuth 
et al and Dixon et al published their classical studies on 
experimental serum sickness in the rabbit. They studied two different 
models, acute serum sickness and chronic serum sickness (75,76).
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Acute immune complex disease
Intravenous injection of radiolabelled bovine serum albumin into 
rabbits was used to study acute serum sickness (75). Intravenous 
injection of the radiolabelled foreign protein yielded a predictable 
non-immune half disappearance time (Tg) in the recipient rabbit thus 
allowing determination of the commencement of disease. After 
injection, radiolabelled BSA was eliminated from the circulation in 
three phases as can be seen from Fig 6.
(1 ) Phase 1 in which BSA equilibrates between intra and extra
vascular spaces.
(2) A slower phase in which BSA is catabolized at about the rate 
of the rabbits own albumin.
(3) A more rapid phase which was thought to be caused by an 
immune elimination of the antigen. After antigen has been 
completely removed from the circulation, free antibody 
appears.
However, of greatest importance was the observation that during the 
phase of rapid elimination of the antigen, complexes of antibody and 
antigen were detected in the circulation and lesions of acute immune 
complex disease developed in arteries, glomeruli, joints and hearts. 
Glomerulonephritis was marked by endothelial swelling with some 
lifting of endothelial cells from the underlying basement membrane. 
Proteinuria was marked with little or no haematuria. BSA antigen, 
host and globulin and C3 were detectable in a granular pattern along 
the GBM. This granular appearance became the hallmark of immune 
complex disease. With the electron microscope, little is seen beyond 
the swelling of endothelial cells. Therefore, acute one shot serum 
sickness resulted in transient renal damage which occurred without the 
participation of complement or polymorphonuclear leukocytes and caused 
no significant permanent structural glomerular damage.
I*BSA ELIMINATION-CIRCULATING BSA ANTI BSA COMPLEXES-DEV. OF LESIONS
100 100
OO
s  10 log
COflD
flO
DAYS AFTER INJECTION OF l*BSA
FIG 6 - EXPERIMENTAL ONE SHOT SERUIÆ SICKNESS (75)
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Chronic immune complex disease
Experimental chronic immune complex disease has been used extensively 
as a model in understanding human glomerulonephritis (76).
Intravenous daily injections of 12.5mg of BSA into rabbits produced 
four responses (Table 3)- Some rabbits failed to produce antibody and 
did not develop any glomerular lesion. A second group produced low 
levels of antibody so that circulating antigen-antibody complexes were 
formed in antigen excess. These small complexes penetrated the 
glomerular loop and produced diffuse glomerulonephritis. A third 
group produced intermediate levels of antibody. In these animals 
daily injections of antigen caused the formation of 
intermediate-sized, poorly soluble circulating complexes which 
localized within the subendothelial mesangial system. Lastly, the 
fourth group produced high levels of antibody which resulted in the 
formation of particulate complexes. These particulate complexes were 
removed by the reticulo-endothelial system and the glomerulus remained 
unaltered. Thus this one model (chronic serum sickness) could cause 
almost all histological changes seen in human GN (ie focal, diffuse, 
membranous). Complexes were identified by discrete deposits of 
antibody and/or complement.
Therefore, in studying the pathogenesis of experimental serum 
sickness, the possibility was considered that immune complexes which 
were found in the tissues were either deposited there from the 
circulation, or formed locally through an Arthus type reaction. Since 
the investigators were able to demonstrate immune complexes in the 
circulation at the time of the development of glomerular deposits, 
they proposed the first possibility as the pathogenic mechanism for 
the glomerulonephritis associated with experimental serum sickness. 
Therefore, the contention was that glomerulonephritis resulted from
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passive trapping of circulating immune complexes. Factors regulating 
the glomerular deposition of circulating complexes have been 
extensively studied and defined. They included systemic factors, 
glomerular factors and properties of the immune complexes themselves. 
Systemic factors included renal blood flow, MPS function and 
erythrocyte C3b receptors which collectively determined the plasma 
level, disappearance kinetics and renal delivery of immune complexes
Glomerular factors included hydrostatic pressure and filtration 
fraction which determined the driving forces by which immune complexes 
entered the capillary wall or mesangium from the circulation (78).
Other glomerular factors included charge and permeability 
characteristics of the glomerulus itself and mesangial clearing 
function (79). Subtle forms of immune deficiency were suggested as an 
enabling factor leading to an inadequate immune response and failure 
to clear the antigen (80). Some evidence for this hypothesis has 
been found. Inherited complement deficiencies have been found more 
commonly than expected in patients with immune complex disease (81).
Mice with an inherited pre-deposition to this immune complex nephritis 
disorder have been shown to produce antibodies of low avidity (82). 
Patients with membranous nephropathy who are DR3 (HLA Type) positive 
have a deficiency in splenic Fc receptors (83). Another factor 
thought to regulate glomerular deposition of immune complex is the 
size of the complex. Germuth suggested that large complexes localized 
in the mesangium whereas smaller immune complexes deposited along the 
GBM. The size of such an immune complex and thereby its site of 
deposition was governed largely by the antigen antibody ratio and the 
size of antigen as demonstrated by the studies of Germuth and Dixon 
(75,76).
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1:2:3 'In Situ’ immune complex formation
Recent studies provide strong evidence for a second mechanism of 
immune complex formation in glomeruli, the reaction of free 
circulating antibody with antigens already present or fixed in the 
glomerulus by mechanisms that reflect properties of the glomerulus 
itself and result in in situ deposit formation (84).
Firstly, the issue of whether preformed immune complexes can be 
passively trapped in a subepithelial site remains controversial (85). 
Secondly, it does not accord with the poor correlation between 
circulating immune complex measurements and glomerular 
immunopathology in some glomerular diseases (86). Thirdly, 
intravenous injection of preformed complexes very rarely causes any 
pathogenic lesion in experimental animal models (87). As a result the 
hypothesis that circulating immune complexes are the only, or even the 
main cause of immune complex glomerular disease is in dispute.
It is interesting to note that the idea that immune complexes may be 
formed locally is more than 75 years old. In 1903, Arthus 
demonstrated that a necrotising vasculitis developed at the site where 
immune complexes were formed in the vessel wall through binding of 
circulating antibody to an antigen which was injected locally (88). A 
few years later Schick put forward the idea that such a pathogenesis 
was operating in glomerulonephritis following a streptococcal 
infection. He supposed that during the infection streptococcal 
products bound to the GBM and later on reacted with antibody which 
originated from the immune reaction of the host (89).
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Experimental in situ immune complex formation
Male Lewis rats immunised with an antigen derived from the luminal 
brush border of proximal tubular epithelial cells (FX1A), developed 
proteinuria and subepithelial immune deposits indistinguishable from 
those in membranous nephropathy in man (90,91). This animal model is 
known as Heymann nephritis after the man who pioneered the studies in 
the late sixties. It was suggested that autologous immune complex 
nephritis (AICN) involved loss of tolerance to tubular antigen which 
was thought to normally circulate in nanogram quantities which led to 
(92,93), antibody formation and deposition of small circulating immune 
complexes. Tubular antigen was identified in circulating immune 
complexes in autologous immune complex nephritis (AICN) rats and was 
present in glomerular deposits in AICN (94). The immunological 
characteristics of the AICN Model were difficult to reconcile with a 
GIG pathogenesis. In AICN subepithelial deposits developed in marked 
antibody excess when antigen was virtually absent from the circulation 
(95). Unless the number of antigenic determinants involved were very 
limited, this situation would have resulted in formation of large 
immune complexes that would be localized in the mesangium rather than 
exclusively in the subepithelial space observed (90).
Evidence for an in situ mechanism for the formation of subepithelial 
deposits were derived largely from studies of the passive Heymann 
nephritis (PHN) model: in which a lesion identical to AICN is produced 
in hours by the administration of heterologous antibody to FX1A in an 
isolated kidney (96,97). This showed that the deposits found in 
Heymann nephritis, previously believed to be the result of trapping of 
circulating immune complexes, containing brush border antigens, could 
be produced by antibody binding to an intrinsic glomerular antigen.
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Couser et al also investigated the mechanism of subepithelial deposit 
formation in PHN in vitro using the isolated perfused rat kidney 
system. A single by-pass system was used which allowed the renal 
venous effluent to run to waste. Granular deposits of IgG were 
demonstrated along capillary walls within 10 minutes by 
immunofluorescence and a membranous pattern of small deposits were 
detected by electronmicroscopy at two hours (98). Van Damme et al 
exposed anti FX1A antibody in vitro to enzyme or acid-treated normal 
rat kidney sections and demonstrated glomerular antibody binding in a 
granular pattern. Moreover they showed that when anti FX1A IgG was 
perfused into a bloodless rat kidney and localized by an 
immunoperoxidase EM technique, antibody binding throughout the 
glomerular capillary wall, including the subepithelial space and slit 
pores, could be demonstrated (99).
These earlier studies provided the first conclusive evidence for the 
in situ formation of glomerular immune aggregates. Subsequent studies 
have extensively re-evaluated the nature of glomerular immune complex 
deposition at mesangial, subendothelial and subepithelial sites as 
discussed below.
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SUBEPITHELIAL GLOMERULAR IMMUNE COMPLEX FORMATION 
Fixed glomerular antigens
Subepithelial immune complex deposits are now believed to form 
primarily on a local or in situ basis rather from circulating immune 
complex trapping. This mechanism however may involve insoluble fixed 
glomerular antigens or exogenous soluble antigens. The best studied 
model of an in situ mechanism involving a fixed glomerular antigen is 
the Heymann nephritis model as discussed earlier (91). The antigen 
responsible for this lesion is now believed to be a glycoprotein with 
a molecular weight of 660,000 daltons (100). The antigen is 
distributed along the glomerular epithelial cell membrane, where it is 
associated with endoplasmic reticulum and coated pits at the cell 
surface. The antigen is apparently cross-reactive with the proximal 
tubular brush border (101).
Neale and Wilson reported in situ immune deposit formation and 
proteinuria due to an endogenous capillary wall antigen (102). They 
showed that a spontaneous nephropathy in NZW rabbits resulted from 
antibody to another non-glomerular basement membrane antigen, which is 
localised along the epithelial cell foot processes and slit pores. 
Except for anti GBM nephritis, no human renal disease has been shown 
to result from antibody reactivity with an endogenous glomerular 
antigen. However, this mechanism has certainly not been excluded 
particularly in membranous nephropathy, in which the lesion closely 
resembles that induced by the Heymann antigen experimentally.
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Planted non glomerular antigens
Subepithelial deposits can also occur in nephritis induced by 
exogenous antigens. Multiple mechanisms have been identified that can 
lead to such planted antigen deposits. Several involve 
charge-dependant mechanisms between the negative charge group in the 
glomerular basement membrane and the cationic antigen. In 1982,
Border et al showed by inducing chronic serum sickness, using cationic 
bovine serum albumin (BSA) rabbits developed predominantly 
subepithelial deposits; independent of the immune response or of the 
quantity and size of the circulating immune complexes (103). Native 
BSA that had not been modified gave rise to mesangial deposits. 
Moreover, they demonstrated the initial binding of cationic antigens 
to the capillary loop using immunofluorescence and radiolabelling 
techniques. However, they showed that the antigen does not persist and 
the disease does not develop unless the antigen is bound to antibody 
and produces immune complexes (104,105).
The mechanism of cationic antigen-induced immune complex nephritis has 
been applied to studies of post-infectious nephritis in humans. Vogt 
et al have isolated several anionic and cationic antigens in 
glomerular immune deposits in 8 of 18 patients with early post 
streptococcal GN (106). Evidence has also been shown for the 
participation of a streptococcal cytoplasmic endostreptosin, in immune 
deposits in patients with early post streptococcal GN (107).
A second mechanism of in situ subepithelial immune complex formation 
related to charge, involves large cationic antigens such as ferritin, 
which may first localise along the subendothelial surface of capillary 
walls. Secondary fixation of antibody leads to formation of large
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latticed subendothelial deposits, which can subsequently dissolve and 
individual reactants can cross the capillary wall to reform as large 
immune complex aggregates in the subepithelial space (108). This 
mechanism may be operative in diseases in which subepithelial and 
subendothelial deposits co-exist as in patients with severe lupus 
nephritis.
Although most attention has been directed at glomerular localisation 
of cationic antigens, anionic antigens such as native BSA and DNA are 
important in producing experimental and clinical immune complex 
nephritis (109,110). Fleuren et al have demonstrated in situ 
subepithelial immune complex formation with native BSA with a pi of 
only 4.6 (111). DNA has also been demonstrated in subepithelial 
immune deposits in patients with membranous lupus nephropathy and has 
been shown to localise in the glomeruli in free form, although it, 
too, is anionic (112,113). Two additional charge-related mechanisms 
may account for the local formation of immune complex deposits 
containing anionic antigens. Anionic antigens may bind to specific 
cationic antibodies already localised in the glomeruli due to their 
charge. This mechanism may account for the finding of Fleuren, Grond 
'and Hoedemaeker with native BSA (111).
Alternatively, anionic antigens may bind electrostatically to 
non-immune cationic proteins that bind to glomerular anionic sites 
prior to immune deposit formation. Evidence for this mechanism comes 
from the work of Chan, Boyd and Fritzler who produced typical 
subepithelial BSA immune complex deposits in mice by first 
administering cationized non antibody IgG folowed by anionic BSA and 
then anti BSA antibody (114).
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Evidence that some mechanism involving exposure of the glomeruli to 
cationic molecules, or other processes leading to loss of anionic 
sites, before immune deposit formation begins, has been provided in 
the NZB/W model of murine SLE, in which loss of glomerular anionic 
sites and increased glomerular permeability appear to precede the 
development of glomerular IC deposits (115). A variety of proteins 
involved in immune reactions are cationic and may be involved in such 
a mechanism (111 ,117).
MESANGIAL IMMUNE COMPLEX DEPOSITS 
Fixed mesangial antigens
No substantial clinical or experimental evidence has been reported of 
mesangial injury or glomerulonephritis caused by antibody reacting 
directly with such intrinsic mesangial structures. However, the 
mesangium exhibits a variety of antigenic determinants that are quite 
accessible to circulating antibodies, including actin, myosin, 
glycoaminoglycan, fibronectin, laminin, type V collagen, procollagen 
type IV and other less well defined antigenic structures 
(118,119,120).
Planted mesangial antigens
The capacity of the mesangium to localise antigens and the 
nephritogenicity of in situ immune complex formation within the 
mesangium, are well illustrated by the studies of Mauer and 
co-workers. Aggregated human IgG was administered intravenously into 
rabbits; it localised without causing injury in the glomerular 
mesangium. Rabbit kidneys containing mesangial human-aggregated IgP 
deposits, were then transplanted into normal recipients (rabbits) who
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were passively administered antibody to'human IgG. The recipients 
developed an acute focal proliferative glomerulonephritis much like 
that associated with mesangial deposits in diseases such as IgA 
nephropathy or lupus nephritis in humans (121). Similar degrees of 
histological and functional glomerular injury have not been produced 
by preformed IC infusion (122). Charge has also been shown to play a 
part in mesangial trapping of potential antigens. Cationic antigens 
have been shown to localize and persist longer at this site (123,124).
The fact that severe glomerulonephritis does not occur by infusion of 
preformed IC, but does occur acutely when similar quantities of IC’s 
form in situ in the mesangium, suggests that in situ formation may be 
a more likely mechanism for causing acute inflammatory lesions in 
diseases such as lupus nephritis, IgA nephropathy and Henoch Schonlein 
purpura.
Non-glomerular antigens
Non-glomerular antigens may cause glomerular injury by two mechanisms. 
Large molecules such as ferritin, which cannot readily penetrate the 
GBM, may localise by charge interaction with anionic sites on the 
inner surface and produce subendothelial deposits (108).
The affinity of certain plant lectins such as concanavalin A (Con A), 
for glucose and mannose residues in capillary-wall glycoproteins can 
result in glomerular localisation of antigen. The studies of Golbus 
and Wilson showed that when anti-con A antibody was injected, a linear 
pattern of IC deposits along the inner surface of the capillary wall 
was produced accompanied by an acute proliferative glomerulo­
nephritis (125). Viruses and other material are known to contain such
43
lectin-like components and may, therefore, have the potential for 
producing deposits by this mechanism in humans (126). Additional 
evidence has come from the work of Batsford who showed that by 
altering the net negative charge of the GBM by infusion of cationized 
ferritin, a nephrotic syndrome resulted 5-7 days later in the apparent 
absence of persistent ferritin or subsequent IC formation in the 
glomeruli (108).
SUBENDOTHELIAL IMMUNE DEPOSIT FORMATION 
Fixed glomerular antigens
There is currently little clinical evidence of a fixed antigen 
mechanism in the development of glomerulonephritis at this site. 
However, nephrotoxic serum (NTS) glomerulonephritis has been reported 
to have been induced in the rabbit by anti endothelial antibodies 
(127). Antibodies to endothlelial cell surface and la antigens have 
been reported in lupus nephritis and would contribute to 
subendothelial deposit formation by this mechanism (128,129).
1:2:4 Prostaglandins and renal disease
Effects of arachidonate oxidation products are diverse and can induce 
most of the major pathophysiological events that characterise the 
inflammatory process. Acting as local hormones, these metabolites, 
therefore, have a profound effect on vascular musculature, platelet 
aggregability and the immunological system. Alterations in the 
balance of the components of this cascade may affect kidney function 
and structure.
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Effect on proteinuria
Indirect evidence that the arachidonate pathways may be activated in 
glomerulonephritis come from clinical and experimental observations. 
Long term cyclooxygenase inhibition with oral indomethacin decreases 
urinary protein excretion in some patients with the nephrotic 
syndrome (130,131)- A single oral dose (75mg) of this non-steroidal, 
anti-inflammatory agent to patients with proteinuria >3g/24 hours (due 
to various forms of immunologically mediated glomerulopathies 
decreases urinary protein excretion within 45-60 minutes, particularly 
when given under conditions of volume depletion (132). The decrement 
in proteinuria exceeds that of glomerular filtration rate. Studies by 
Tiggler, Hulme and Wijdeveld have demonstrated that in patients with 
the nephrotic syndrome, indomethacin decreases proteinuria and the 
glomerular permeability to macromolecules such as 
polyvinylpyrrolidone, by influencing intrarenal and glomerular 
hemodynamics presumably as a result of PG synthesis inhibition (133).
Effect on glomerulonephritis
Certain prostaglandins, particularly of the E series, appear to have a 
beneficial effect on the progression of certain forms of 
glomerulonephritis. Pharmacological doses of PGE^ alter the course 
of lupus glomerulonephritis both in NZW/W and in MRL/1 mice (134,135). 
A pronounced increase in mouse survival and striking reductions in the 
amounts of immune deposits in renal glomeruli were noted. In 
addition, PGE^  treatment reduced the levels of circulating immune 
complexes in both strains (136).
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Recently, several reports have shown the effects of dietary 
polyunsaturated fatty acids (PUFA) on immune complex forms of 
glomerulonephritis and on the progression of animal models of chronic 
renal disease. Dietary enrichment with the polyunsaturated fatty acid 
eicosapentanoic acid, prevented proteinuria and prolonged survival in 
NZB/NZW mice (137). A high linoleic acid diet had a protective 
effect on the development of murine apoferritin-induced immune complex 
nephritis (138).
Role in renal failure
PUFA’s are precursors of the prostaglandin (PG) thromboxane (Tx) 
family and of the leukotrienes. This may provide a possible 
explanation for the beneficial effects on the kidney of altering the 
supply of PUFA's in the diet. The PG - Tx metabolites are formed 
through the cyclooxygenase and the leukotriene metabolites through the 
lipooxygenase pathways. Acting as local hormones, these metabolites 
have profound effects on vascular musculature, platelet aggregability 
and the immunological system. Alteration in the balance of the 
components of this cascade may affect the kidney function and 
structure. That these polyunsaturated fatty acids are important 
factors in the maintenance of renal function is suggested by the 
findings of Kimberly and Plotz (139) in patients with systemic lupus 
erythematosus and those of Ciabattoni et al in patients with 
glomerulonephritis (140). Both groups reported that cyclooxygenase 
blockade had deleterious effects on renal function in these two groups 
of patients with impaired renal function. The increased prostaglandin 
found in patients with chronic renal disease may suggest a 
compensatory mechanism when renal function is decreased (141). 
Injections of pharmacological doses of prostaglandin or substances 
that block synthesis of thromboxane, have been shown to have 
beneficial effects both in various models of renal disease and in
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humans with diminished renal function due to chronic 
glomerulonephritis (142).
47
SECTION 1:3:1 
Aims of the study
The glomerulopathies are a group of disorders in which the main 
abnormality occurs in the glomeruli or filtering units of the kidney. 
They are the cause of renal failure in one third of the patients on 
dialysis in Europe. The two commonest glomerulopathies, which 
together account for nearly one half, are membranous and IgA 
nephropathies (23% each in Glasgow Royal Infirmary). Both types of 
glomerulopathy are mediated by immune complexes but in membranous 
nephropathy, the complexes form on the basement of the capillary wall 
whereas they are found in the mesangium in IgA nephropathy.
No adequate explanation has yet been found to account for individual 
susceptibility or resistance to a particular nephropathy. Immune 
complexes are thought to be common mediators of glomerular disease, 
but are frequently detected in the sera of patients whose renal 
function and structure is normal and conversely are often not detected 
in patients with glomerulonephritis. More recently the charge of the 
antigen has been shown to be an important factor in its site of immune 
complex deposition within the kidney.
In this thesis, the postulate that the role of the glomerulus itself 
may play an important part in determining the response of the 
glomerulus to injury was investigated. The specific aims of this 
thesis are as follows:
(1 ) To examine two glomerular properties to see if they
influence renal handling of antigen.
a Charge on the glomerular basement membrane
b Mesangial uptake of proteins
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These properties were examined in two strains of rat; 
one of which is susceptible to Heymann nephritis and the 
other of which is resistant.
(2) To study the consequences of different glomerular 
properties on various animal models of glomerular injury,
(3) To investigate the effect of prostaglandins and their 
precursors in modulating glomerular uptake of antigens.
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CHAPTER TWO 
MATERIALS AND METHODS
SECTION 2:1:1
The materials and suppliers used for the following experiments are as 
follows :
BDH CHEMICALS LTD
SIGMA CHEMICALS LTD
DIFCO LABORATORIES
AMERSHAM RADIO-CHEMICAL 
CENTRE LTD
CLAY ADAMS
MAY & BAKER
OLAK
SPECIAL DIET SERVICES
Sodium chloride (NaCl)
Potassium dihydrogen orthophosphate 
(KHgPOy)
di-potassium hydrogen orthophosphate 
(KgHPO^ )
Puromycin Aminonucleoside (PA) 
Hexadimethrine (HIH)
Human IgG
Human serum albumin (HSA)
1-ethyl 3 (3 dimethylaminopropyl) 
carbodiimide hydrochloride (EDC)
N, N dimethyl 1-3 propanediamine (EMPA) 
FITC conjugated antihuman IgG 
FITC conjugated anti rat IgG 
Freunds complete adjuvant.
1-125, 1-131
Polyethylene tubing PEI 0, PE50, PE90 
Sodium pentobarbitone (60mg/100ml) 
Inbred DA and Lewis rats.
Fat-free diet
Rat and mouse Nol expanded diet.
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KODAK LTD
MACFARLAN SMITH
BRITISH PETROLEUM 
CHEMICALS
WELLCOME REAGENTS LTD
MILES LABORATORIES 
INCORPORATED
PARK DAVIS & CO
BRITISH OXYGEN CO
High speed ektachrome film
Anaesthetic ether
740P Methylated spirits
Mouse liver powder 
Tissue Tek II OTC compound
Gelatin capsules, size 00 
Liquid nitrogen
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METHODS 
SECTION TWO
2:2:1 Modifications of Proteins
Cationization of proteins was performed according to the method of Danon 
et al (143), using 1 ethyl 3 (3 dimethylaminopropyl) carbodiimide 
hydrochloride (EDC) as activator and N,N dimethyl 1 ,3 propanediamine 
(DMPA) as a nucleophile to replace carboxyl groups. The reaction is 
based on the activation of the carboxyl groups of the protein to be 
modified with a water soluble carbodiimide (EDC) and the subsequent 
reaction of the activated carboxyl with a nucleophile of the general 
type (+RNH), such as DMPA, to obtain the tertiary amine type 
derivatives. The following procedure was used:-
(1 ) The required amount of protein (16mg) was measured out and
dissolved in 0.5ml of buffer A pH 5.5 (see appendix for buffers).
(2) 20ul of DMPA was added to 250ul of buffer A.
(3) 30mg of EDC was dissolved in 250ul of buffer A.
The three reactants were quickly mixed together and allowed to stand 
overnight at room temperature. The reaction mixture was then dialysed 
three times in large volumes of working buffer pH8.6. The degree of 
cationization was estimated by isoelectric focusing. The reaction 
conditions produced cationized human IgC} with a pi exceeding 9.5 and 
human serum albumin with a pi exceeding 8.0.
52
2 :2 :2 Determination of isoelectric point
The isoelectric range of the modified proteins was determined by 
isoelectric focusing in thin layers of polyacrylamide gels, pH range 
3-10, using a Pharmacia flat bed electrophoresis unit (FBE 3000) with 
accompanying power supply (ECPS 3000/150). The following procedure was 
carried out:-
1 Preparation of agarose solution
0.3g isoelectric focusing agarose , 3-6g sorbitol was 
dissolved in a conical flask by heating in a boiling water 
bath.
2 Mould preparation
While the agarose was being dissolved the mould was set up.
(a) It was ensured that the levelling table was horizontal 
using a spirit level.
(b) 2ml of distilled water was poured into the levelling table.
(c) A sheet of gel bond with the hydrophilic surface up was placed 
onto the levelling table. Agarose will adhere only to the 
hydrophilic side.
(d) The film was rolled so that it was flat against the levelling 
table and excess moisture and air bubbles were removed from 
the gel.
(e) The gel casting frame was placed in position over the plastic 
film and the edges fastened down with six spring clips.
(f) The levelling table and plastic was prewarmed.
3 Moulding
(a) The agarose gel solution was allowed to cool to around 75 C.
The Pharmalyte (pH 3-10) was added, mixed and then poured into
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the mould. The flask was moved around so that the solution 
flowed to all corners of the mould. Air bubbles were avoided,
(b) Once the gel had set (10-15 minutes) a scalpel was run around
the edge of the gel casting frame and the gel. The plastic 
film was removed from the levelling table by levelling with 
a scalpel from one end. The gel was allowed to harden fully 
before use (1 hour at 4°C).
Running the experiment
1 The gel was placed on the flat bed cooling unit. The
electrode strips were soaked in the appropriate electrode
solutions
Cathode IM NaOH 
Anode 0.05M H^SO^
The strips were blotted on filter paper for about one minute
to remove excess liquid. The gel was prefocused at 500 volt
hours.
2 The samples and a pi calibration kit pH 3-1 0 was
applied using the paper sample applicators. Up to 25ul can 
be applied on the filter paper applicators.
3 The power supply was set to deliver a maximum of 15W and 1 500V
with unlimited current and was run for 90 minutes.
4 The sample applicators were removed after 45 minutes.
Fixing and staining
See appendix for fixing and staining solutions.
1 The gel was fixed immediately after the run was completed in
the fixing solution for 30 minutes.
2 The gel was washed in two lots of destaining solutions, each
for 1 5 minutes.
3 The gel was dried before staining. Three layers of filter
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paper were placed carefully on top of the gel followed by a 
glass plate and weight of about 1kg. After 15 minutes, all 
this was removed and the gel was dried with a hair dryer.
4 The film was placed in staining solution for 5 to 10 minutes.
5 The gel was destained until the background was clear (15- 
20 minutes).
6 The film was dried with a hair dryer.
Determination of pi using standard curve
1 A piece of graph paper with 1 cm markings and 0.1cm sub­
divisions was used. The gel was positioned over the grid so 
that the origin of the grid was lined up with the cathode and 
of the gel.
2 Using the grid, the distance from the cathode of each protein 
pi marker to the nearest 0.05cm was determined.
3 The known pi value of each pi marker versus its distance 
from the cathode was plotted. Fig 7
4 The distance from the cathode of the proteins of interest 
to the nearest 0.05cm using the grid was determined.
5 From the pi calibration curve and known distances of the 
protein(s) of interest from the cathode the pi of the 
protein(s) was determined (Fig 8).
^5-------- ^  Temperature gradient
pH gradient measured by 
microeiectrode 
pH gradient via pi markers
10.00
9.50
9.00
lentil lectin-Oasic
lentil lectln-middle 
— lentil lectin-acidic
8.50
8.00
horse mycgiooiin-basic
7 00 horse myoglopm-acidic
TQ,— human cartjonic anhyOrase 86.50
6.00 Povine cartjonic anhyorase B
5.50
/i-lactoglobulin A
5.00
4 50 soyt>ean trypsin inhibitor
4.00
3.50 amyioglucosidase
3.00
1.0 7.0 9.02.0 4.0 5.0 6.0 8.03.00 Temp “C
Distance From Cathode (cm)
FIG 7 Determination of pH Gradient Profile using the 
Broad pi Calibration Kit on a 5% PAA Gel 
containing Pharmalyte 3-10.
ISOELECTRIC FOCUSING GEL (Fig 8)
12 11 10
Well No 1 2 7 8 contain standard samples
4 6 10 12 contain IgG+
N
3 5 9 11 contain IgG
+ ve
amyioglucosidase (p I -3 .5 0 )
soybean trypsin  in h ib i to r  (p I -4 .5 5 )
B - lactoglobulin  A (p I -5 .2 0 )
m g  Imi
bovine carbonic anhydrase B (p I -5 .8 5 )  
human carbonic anhydrase B (p I -6 .5 5 )  
myoglobin-acidic ( p i -6 .8 5 )  
myoglobin-basic ( p I -7 .3 5 )
l e n t i l  l e c t in  ac id ic  (p I -8 .1 5 )  
l e n t i l  le c t in  middle (p l -8 .4 5 )  
l e n t i l  l e c t in  basic (p I -8 .6 5 )
trysinogen (p I -9 .3 0 )
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2:2:3 Alkali aggregation of human IgG
IgQ was aggregated using the method described by Whaley et al (144). 
Equal volumes of human IgG (20mg/ml) and sodium hydroxide (200mmol/l) 
were mixed at room temperature and then dialysed extensively against 
phosphate buffered saline. This procedure allows the pH to fall 
gradually to 7.2 and retains the aggregates in a soluble form. The 
degree of aggregation was checked using SDS electrophoresis.
2:2:4 Radiolabelling of proteins
Human IgG and HSA were iodinated with 1-125 and 1-131 respectively by 
reaction with iodine monochloride (145). This procedure introduced 
an atom of iodine into the phenolic ring structures of tyrosine 
residues. The following methods and experimental procedure was used.
Materials
(1 ) Iodine monochloride (ICI) (25nmol/ul)
(2) IM Glycine buffer pH 10.0.
7.15g glycine was made up to 100ml with deionized water and 
adjusted to pH 10.0.
Method
(1) The protein was assayed using the Lowry method (146).
(2) The concentration of ICI: protein being 2.5:1 .
(3) The volume of glycine buffer to be used was estimated;
250ul buffer/Iml of protein.
(4) The volume of isotope used was either ImCi 1-125 ImCi 1-131
in lOul of dilute sodium hydroxide.
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Procedure
(1) 1ml of protein was added to a L?3 tube. 250ul of glycine 
buffer was added.
(2) To this mixture 1 Oui of either 1-125 or 1-131 was added.
(3) The appropriate volume of ICI to be used was put in the L?3
cap, the cap was placed on the tube and mixed quickly by 
inversion.
(4) Free iodine was removed by dialysis using large amounts of
working buffer. The buffer was changed 4 or 5 times until 
only minimal radioactive counts could be detected in the 
buffer.
Preparation of injectable doses of protein
After radiolabelling the protein concentration was reassayed using the 
Lowry method (146). The concentration was then adjusted so that the 
dose administered to the rats was in a volume of 0.1ml. The protein 
solution was drawn up into 1ml syringes. The syringes were weighed 
before and after injection.
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SECTION 2:3:1
IMMUNOFLUORESCENT TECHNIQUES 
Absorption of antisera
Conjugation of FITC to protein causes an increase in the net negative 
charge of some serum proteins and these may bind to tissue sections 
resulting in excessive background staining. These highly negative 
charged proteins can be removed either by absorption with tissue 
powders or by ion exchange chromatography. The former method was 
found to be effective and convenient and was, therefore, used for the 
absorption for all FITC conjugated antisera before being used in the 
immunofluorescence test. Mouse liver powder was washed twice in PBS, 
centrifuging at lOOOg for five minutes and then incubated with the 
antiserum for one hour at room temperature on a Matburn mixer. This 
mixture was centrifuged at lOOOg for five minutes and the procedure 
repeated. The supernatant resulting from the second absorption was 
centrifuged a second time to remove any trace of liver powder and was 
aliquotted and stored at -20**C.
RENAL IMMUNOFLUORESCENT METHODS 
Freezing and storing rat kidney material
The rat kidneys were cut in half longitudinally and cortical samples 
taken from both poles. The section was immersed immediately in 
Tissue-Tek II contained within a gelatin capsule. The piece of cortex 
was aligned horizontally within the upright capsule, frozen in a 
mixture of dry ice and methylated spirit and stored in a nunc tube at 
-70*C till required.
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Immunofluorescence test
Using a Slee cryostat, 4jLt sections were cut from the embedded renal rat 
cortex and air dried for 30 minutes. Sections were washed twice for a 
total of 20 minutes in PBS while shaking on a G riff en flask shaker.
These sections were then fixed for 10 minutes in ether alcohol at 4* C 
followed by 90% alcohol for 20 minutes at 4®C and washed 3 times in PBS 
for 15 minutes. The glass slides were dried leaving the sections moist 
and the sections were incubated with one drop of the relevant antiserum 
in a humid chamber for 30 minutes at room temperature. This was 
followed by 3 washes in PBS for 20 minutes, sections were then mounted 
in citifluor. Control sections from each kidney were tested each time.
(a) One section was incubated with PBS rather than antisera 
during each incubation.
(b) Normal rat kidneys of the same strains were incubated 
either with PBS or the appropriate antisera during each 
incubation.
Microscopy and photography
The microscope used was a Leitz Ortholux II with a high pressure 
mercury vapour lamp, HBO 200 light source, a BG38 heat filter, a 4mm 
BG12 interference filter, an inbuilt barrier filter at setting 3 and a 
supplementary barrier filter, K510. This system is designed to allow 
only light below a wavelength of 490nm to reach the tissue and only 
light above 520nm to reach the eye pieces since the peak of FITC 
absorption is at 490nm and the peak emission is at 520nm.
The specimens were examined within 24 hours of being stained. Sections 
were usually viewed using xIO wide-field eye pieces and a x40 objective 
lens. Only where localization of staining was difficult was an oi
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immersion xlOO objective lens used.
All sections were assessed for intensity of stain on a scoring system 
of zero to three, zero = negative, one = weak, two = moderate, 
three = intense.
The sections were also described according to the pattern of staining, 
CL = capillary loop and M = mesangial.
All photography was done using a Zeitz Orthomat camera attachment.
The observer did not know the source of the sections examined.
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SUMMARY OF IMMUNOFLUORESCENCE METHODS
1 Embed rat cortex in Tissue-Tek in a gelatin capsule 
and snap freeze immediately.
2 Store at -70°C in a sealed container.
3 Cut frozen sections.
4 Air dry for 30 minutes.
5 Wash in PBS, 2 x 1 0  minutes.
6 Fix in ether alcohol at 4°C for 10 minutes.
7 Continue fixation in 95% alcohol at 4°C for 20 minutes.
8 Wash in PBS, 3 x 5  minutes.
9 Incubate with antisera in humid container, 30 minutes.
10 Wash in PBS 3 x 7  minutes.
11 Mount in citifluor.
12 Examine sections and photograph.
1 3 Store at 4°C in the dark.
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SECTION 4 
ANIMAL STUDIES
Two strains of rat were used in this study. The Lewis strain (Fig 9) 
and the DA strain (Fig 10). Rats of 200-250g were used in all the 
experiments apart from the diet feeding experiments when lOOg rats were 
used.
Healthy male rats were used throughout the study unless indicated.
2:4:1 RENAL UPTAKE OF PROTEINS
Changes in renal uptake with time
The rats were placed into a jar containing ether. When the rats were 
slightly anaesthetised they were removed from the jar. The rats were 
placed on a thermoregulated electric blanket ; the blanket was connected 
to a homeothermic control at 37*C which maintained body temperature at 
37.0 +  0.5 C.
An incision was made in the neck and the jugular vein exposed by blunt 
dissection. Intravenous injections of proteins were given into the 
jugular vein under ether narcosis. Cationized IgQ, native Igl and 
aggregated IgO were given at various times and in doses of 0.25mg, Img 
or 5mg. The animals were sacrificed and the kidneys, liver and spleen 
were removed. The uptake of the various proteins was measured by 
counting one whole kidney, liver and spleen. Sections of the other 
kidney were snap frozen in liquid nitrogen and the site of deposition
FIG 9 - LEWIS RAT
FIG 10 - DA RAT
'#^ 0
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of I g] determined by standard immunofluorescent techniques using FITC 
anti human IgG. The uptake of cationic IgG by female Lewis and DA 
rats was studied at 1 hour and 3 hours using the same technique.
2:4:2 Renal artery perfusion studies
The procedure used was that described by Hoyer (147). Rats were 
anaesthetised with ether and the abdominal cavity exposed through a 
mid-line incision. The aorta and inferior vena cava were exposed by 
blunt dissection. The left spermatic and adrenal arteries were 
ligated and divided. Clamps were then placed across the aorta and 
inferior vena cava above and below the left renal artery. The origin 
of the right renal artery was outwith the clamps. A small incision 
was made in the left renal vein. 1ml of saline was infused over 20 
seconds into the left renal artery through a 26 gauge needle placed in 
the aorta between the clamps. Varying quantities of IgG (5ug, 50ug 
and 200ug) were then infused in a volume of 0.1ml followed by 1ml of 
saline. The perfusate which leaked through the incision in the renal 
veins was removed by gauze swabs. The incisions in vein and artery 
were repaired with 7-0 silk sutures. The clamps were removed 
following total ischaemic time of less than 15 minutes. The abdomen 
was closed in 2 layers with 4-0 sutures. The animals were sacrificed 
15 minutes after infusion of IgG, the kidneys removed and the uptake 
of IgO in both kidneys measured.
2:4:3 Changes in glomerular permeability caused by IgG
This was assessed in two ways :- 
(1 ) 5mg of 1-125 IgG**” was injected IV via the jugular vein at
time zero. Fifteen minutes later 5mg of 1-131 HSA was given 
TV. The rats were housed in metabolic cages and all urine
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collected over the next 24 hours. The urine was dialysed 
against a large volume of buffered saline and the urinary 
excretion of HSA measured.
Control rats were given 1-131 HSA only and housed in 
metabolic cages for 24 hours. There were 6 rats in each 
group.
(2) The second method of assessing glomerular permeability was
to measure the increased renal uptake of HSA resulting from a
1mg bolus of IgC"^ . One group of rats had only Img of HSA
injected with no prior IgG given, the rats were sacrificed
at 15 minutes and the renal uptake measured (HSA ). A
second group of rats were given Img of IgG'*’ IV at various
times followed by Img HSA 15 minutes before sacrifice and the
renal uptake measured (HSA ). The baseline value was then
substracted from the renal uptake of HSA given 15 minutes
before sacrifice following IV injections of IgG"*",
ie, HSA - HSA .’ c s
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2:4:4 Charge on red cells in DA and Lewis rats
The method used was that described by Levin (148). The rats were bled 
out through the abdominal aorta. Nine volumes of blood were mixed with 
one volume of 3.8% trisodium citrate. The red blood cells were 
separately centrifuged and washed three times in phosphate buffered 
saline, and resuspended in the same buffer in a final concentration of 
1.2 X 1 O^ml.
Anionic sites on the red blood cells were quantified by the binding of 
the cationic dye alcian blue 8 GX (AB). The optical density of AB at 
650mm is linearily related to its concentration (Fig 11). Suspensions 
of rbc’s from the two strains of rat were incubated with solutions of AB 
at varying concentrations and the amount of dye bound to the cells was 
calculated from the difference in optical density, between the original 
solution and the supernatant after removal of the cells by 
centrifugation.
Effect of [AB] on alcian blue binding
1ml of a suspension of rbc’s (1.2 x 10^/ml) was incubated with 1ml of 
a solution of AB varying in concentration from 10 to 2000pg/ml and 
incubated at 37 °C for 30 minutes. After removal of the cells by 
centrifugation, the optical density of the supernatant was measured. 
The amount of AB bound per 10^ cells was plotted against the residual 
(free) AB concentration. This showed a sigmoid curve indicating 
saturation of binding sites at AB concentration above 600jUg/ml 
(Fig 12).
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2:4:5 Charge on red cells in patients with different glomerulopathies
The charge on the red blood cells was examined in three groups of 
patients all of whom were in complete or partial remission. The three 
groups of patients were defined by the appearance of their renal biopsy 
and comprised patients with IgA (IgAN) membranous (IMN) and minimal 
change (MCN) nephropathies. A group of controls made up of hospital 
staff was also studied. Thirteen patients had IgAN (9 men and 4 women). 
Their mean age was 34.8 (range 17-55). Ten still had haematuria, one 
was receiving atenolol for hypertension, one was receiving glyceryl 
trinitrate, nifedipine and a diuretic, and one had steroid and 
salbutamol inhalers for asthma.
Ten patients had had one or more episodes of nephrotic syndrome due to 
minimal change nephropathy. Their mean age was 45.4 years (range 
24-73), five of which were male. None was receiving prednisolone at the 
time of study.
Twelve patients with IMN had presented with nephrotic syndrome but were 
in complete or partial remission at the time of biopsy. Three had taken 
part in the MRC study and previously may have had steroids. None was 
receiving steroids at the time of study. There were three women and 
nine men with a mean age of 48.4 years (range 25-66). 24-hour urines 
were measured for proteinuria. Details of quantitative proteinuria and 
creatinine clearance can be seen in table 4 for all groups of patients 
studied.
T A B L E  4
----------- -
PATIENT NEPHROPATHY QUANTITATIVE MEAN CREATININE CREATININE
PROTEINURIA PROTEINURIA CLEARANCE CLEARANCE
g/24 hrs g/24 hrs ml/min MEAN =+|SD
1 0.47 143
2 0.01 114
3 0.63 77
4 0.05 123
5 IgA 0.21 0.56 ND 100.8+30.7
6 0.40 65
7 0.05 120
8 0.23 130
9 2.3 50
10 0.24 125
11 0.23 84
12 0.82 122
13 1.70 57
1 0.24 144
2 1.95 78
3 0.05 107
4 0.07 148
5 0.06 56
6 IMN 0.57 0.33 69 93.9+26.4
7 0.11 116
8 0.80 86
9 0.12 82
10 0.04 98
11 0.04 57
12 0.06 116
1 1.59 164
2 0.05 101
3 0.07 104
4 0.05 162
5 0.03 103
6 MCN 0.01 0.25 143 124+25.4
7 0.03 103
8 0.63 111
9 0.09 104
10 0.05 150
----------- J
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Measurement of charge
This was carried out using the same protocol as described previously. 
Two different concentrations of alcian blue 125jUg/ml and 250jug/ml were 
used. Patients were venesected in the morning and the test carried out 
soon after. Each test was performed in triplicate.
Competitive inhibition of alcian blue binding by polycations
Increasing concentrations of protamine sulphate or hexadimethrine were 
added to produce a dose dependant inhibition of alcian blue binding to 
normal red blood cells.
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SECTION 5
Experimental animal models of glomerulonephritis
Four different animal models of glomerulonephritis were investigated in 
the two strains of rats and the effects of their different glomerular 
properties on their response to these models were examined.
2:5:1 Heymann nephritis (autologous immune complex nephropathy)
Male Lewis and DA rats (200g) were used. There were 4 animals in each 
group.
Preparation of crude kidney fraction
This was carried out following the method of Edgington (149). The 
proximal tubule brush border named FX1A was lyophilised and stored at 
-20 °C. (This antigen was kindly donated by Dr M E M Allison).
Induction of Heymann nephritis with FX1A
12.5mg of FX1A was mixed with 0.25ml of 0.9% saline which was then 
emulsified with the same volume of Freunds complete adjuvant. 0.5ml of 
the mixture was then injected intradermally at several sites into the 
rat's back. Control rats were injected with Freunds complete adjuvant 
only. 24 hour urines were collected at fortnightly intervals for 20 
weeks.
Estimation of proteinuria
24 hour urine collections were made fortnightly. Protein content was 
determined by using the Rice method (150). The mean proteinuria of 
non-immunised rats was < lOmg/day. Proteinuria of 1Omg or greater per 
day was considered abnormal and was accepted as presumptive evidence of 
disease. Section of kidney cortex were fixed in 2% gluteraldehyde 
phosphate buffer and prepared for electron microscopy studies. EM 
studies were kindly done by Dr A McLay (Pathology Department, Glasgow 
Royal Infirmary).
68
2:5:2 Chronic serum sickness model
This model was first described by Border in rats and demonstrated that 
by injecting cationized HSA intravenously on alternate days, mesangial 
deposits developed (124). Interestingly, when the experiment was 
repeated in rabbits membranous deposits evolved (103).
Experimental protocol
The method used was a modification of the procedure by Border (124).
Male Lewis and DA rats (200g) were immunised with an intravenous 
injection containing Img of cationic HSA and lOug endotoxin, as adjuvant 
under ether narcosis. One week later, intravenous injections of Img of 
cationic HSA were given until day 21 when the rats were sacrificed and 
renal tissue taken for immunofluorescence studies.
Prior to immunisation and during the course of the experiment, animals 
were housed in metabolic cages and 24 hour urine collections were 
obtained for protein estimations. Urinary protein was quantified by 
the Rice method (150).
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2:5:3 Infusion of hexadimethrine
Hexadimethrine is a polycation and was used to test the hypothesis that 
neutralization of polyanion of the glomerular basement membrane will 
lead to loss of charge-dependant glomerular permselectivity.
Experimental protocol
The experimental procedure used was that described by Hunsicker et al 
(117). Male Lewis and DA rats (200g) were used in this study. There 
were six rats in each group. Each rat was pretreated with an 
intraperitoneal injection of diphenhydramine (25mg/kg) to reduce HH4 
toxicity related to histamine release from mast cells. The rats were 
anaesthetised with sodium pentobarbitone 60mg/kg body weight 
intraperitoneally. While under anaesthesia, an IV polythene catheter 
(PE50) was introduced into the jugular vein and the rats volume expanded 
over a period of 10 minutes with a quantity of saline equal to 5% of the 
body weight. The bladder was catheterised with PE90 tubing. Each 
animal was then permitted to equilibriate for 30 minutes on a saline 
infusion at a rate of 0.24ml/min. After equilibration an infusion of 
H m  (0.33mg/ml in 0.9% saline) was begun at the same rate of 0.24ml/min 
for 60 minutes and then saline was infused again at the same rate for a 
further 40 minutes. Sequential 10 minute urine collections were 
obtained throughout the study into pre-weighed vials containing paraffin 
oil. Volumes were determined by weight assuming a specific gravity of 
1.0. Protein content was estimated by the Lowry method.
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2:5:4 Puromycin aminonucloeoside nephrosis (PAN)
Puromycin aminonucleoside causes proteinuria five days after a single 
intra peritoneal injection in rats. The only histological change is 
epithelial foot process fusion therefore, it is suggested that PAN is 
associated with minimal change nephropathy. However, experimental 
animal models have produced conflicting views on the pathogenesis of PAN 
nephropathy and, therefore, the above view may be erroneous. Thus, 
the effect of puromycin aminonucleoside (PA) on the two strains of rat 
was studied.
Experimental Protocol
Male Lewis and DA rats (200g) were used in this study. There were eight 
rats in each group. All animals used were housed in individual 
metabolic cages with free access to standard rat chow and water.
Initial urine collections were obtained twice during three days before 
PA administration. All rats had less than 10mg/24 hours of protein in 
their urine which was considered normal.
The rats received one 16mg dose of PA intraperitoneally. 24 hour urine
collections were measured on alternate days over a period of three 
weeks. Urinary protein content was estimated by the Rice method.
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2:6:1 Measurement of PGI^ in aortic rings
Aortas were removed from male Lewis and DA rats and PGI^ levels measured 
using the method of McLaren et al (151). Aortas were placed immediately 
into Hartmann's solution after removal from the body (six aortas taken from 
six separate Lewis or DA rats were used). The aortas were cleaned, freed 
from any fatty tissue and then chopped into pieces about 10mm long. They 
were then blotted once on a piece of filter paper and weighed. Pieces of 
similar weight were used for the experiments and incised longitudinally to 
allow maximum exposure of the endothelium. They were then incubated in 
Hartmann's solution at 37 °C and the buffer changed at various intervals 
as shown below.
SAMPLING TIME VOL BUFFER
15 minutes 10ml
30 minutes 10ml
45 minutes 10ml
60 minutes 10ml
90 minutes 5ml
2 hours 5ml
2j hours 5ml
3 hours 5ml
4 hours 5ml
5 hours 5ml
6 hours 5ml
7 hours 5ml
8 hours 5ml
9 hours 5ml
PGI^ levels in the sequential supernatants were measured. The amounts 
of PGI^ released per minute was calculated (ng/min).
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SECTION 6
2:6:2 Modulation of glomerular properties by prostaglandins 
and their precursors
Quite recently there has been considerable interest in the role of 
prostanoids in the kidney. Experimental reports have shown beneficial 
effects of some prostanoids in modulating the course of some animal 
models of glomerulonephritis.
The effect of different fatty acid diets, fed over a six week period to 
the two strains of rat, on the glomerular uptake of proteins was 
examined.
Experimental protocol
A fat free diet was prepared by Special Diet Services (Essex). lOOg 
male Lewis and DA rats were used in the study. The rats were divided 
into five groups as illustrated below. The oils were kindly donated by 
Efamol (Guilford). The composition of oils is illustrated in table 5.
OIL fCTDJE INGREUIENr PG HOXIES
CPI FAT FREE DIET + SAFFL£WER OIL ARACHIDONIC ACED 2-SERIES PG
CP2 FAT FREE DIET + FISH OIL EICOSAPENIAENOIC ACID 3-SERIES PG
(P3 FAT FREE DIET + EVENING PRIMROSE OIL GAFMA LINOLEIC ACID 1-SERIES PG
GP4 FAT FREE DIET + OLIVE OIL OLEIC ACID (Inert) —
CP5 NORMAL DIET - -
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The basic recipe used was as follows
43ml oil 
500g fat free diet 
2.7g butylated hydroxy tolulene 
150ml diethyl ether
The oil; ether and tolulene were mixed together. This mixture was added 
to the fat free diet and thoroughly mixed. It was then put in the 
drying oven overnight to allow the ether to evaporate.
The rats were weighed before and twice weekly during the six weeks to 
make sure they were feeding on the diet.
Glomerular uptake of cationized IgG
At the end of the 6 weeks the rats were injected intravenously with 
1-125 cationized IgG"^  (Img) as previously described. The rats were 
sacrificed one hour after the injection of IgG"*" and one kidney counted 
in a Beckmann Gamma counter and the other kidney taken for 
immunofluorescence studies.
Kidney sections were stained with FITC anti human IgG and FITC anti rat 
IgG by standard immunofluorescent techniques.
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2:6:3 Renal infusions of PGE^ , PGI^ 
Operative procedure
The rats were anaesthetized with sodium pentobarbitone (0.1 ml/1 OOg) and 
placed on a thermoregulated blanket as before. Two PE50 cannulae, one 
containing saline (sodium chloride solution, 154nmol/l) and the other 
containing heparinised saline (30iu/ml) were placed in the right jugular 
vein and right carotid artery respectively. Blood pressure was 
continually recorded from the carotid artery with a blood pressure 
transducer (Bell & Howell) and a MX4 4 channel recorder (Devices). The 
recording system was calibrated with a mercury monometer from zero to 
140mm Hg by step wise (20mm Hg) increases in pressure. The blood 
pressure was measured to within +  2mraHg.
Experimental protocol
PGI^  was supplied by the Wellcome foundation Ltd, London in a vial 
containing 0.5mg. This was diluted in 50ml of glycine buffer pH 10,5. 
1ml of this solution was then further diluted 1/100 with more glycine 
buffer giving a final concentration of lOOng/ml. PGE^  was supplied by 
Upjohn, West Sussex, in a concentration of 500|ig/iiil. This was diluted 
with saline to give a final concentration of 500ng/ml. The biological 
activity of these very dilute solutions of PGIp and PGE, was checked 
by measuring their ability to inhibit platelet aggregation. Biological 
activity was found to be present. PGE. and PGI^  or glycine buffer 
were infused via the jugular vein at a rate of 0.05ml/min using a 
Harvard infusion pump and continued for 3 hours. Blood pressure was 
monitored continually. Two hours after the start of the infusion, IImug 
of radiolabelled cationic IgG was given via the jugular cannula, 
uptake of IgG"*" was measured in one kidney in a Gamma counter, 
other kidney was taken for iimmunofluorescent studies.
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CHAPTER 3 
SECTION I
RENAL UPTAKE OF PROTEINS
3:1 :1 Changes in renal uptake with time
The renal uptake of IgC"^  (cationized IgC) and IgC^ (native IgO) are 
shown in Figs 13 and 14 respectively. There was significantly less 
uptake in the kidneys of male Lewis rats at all times compared with DA 
rats. The specific uptake of IgG due to charge (IgG'*’ - IgG^) is 
shown in Fig 15 and was also greater in DA rats at all times except 24 
hours when there was no specific uptake.
3:1:2 Effect of dose of IgC'*' on renal uptake
The effect of dose on IgG on renal uptake was examined in the 2 
strains of rat one hour following 0.25mg, Img or 5mg of IgG given 
intravenously (table 6). The renal uptake in Lewis rats was 50.0% that 
of DA rats at the lowest dose but rose to 70.8% following the highest 
dose. Therefore, the greatest relative difference followed the smallest 
dose of IgG but the difference in absolute amounts was greatest after 
5mg.
3:1 :3 Renal artery perfusion studies
The uptake of IgC"^  (in jJig/g, of kidney) by the kidney of the 2 strains 
of rat 15 minutes following injections of 5,50 and 200/ig of IgG into the 
left renal artery was as shown in Table 7- The amount deposited in the 
left kidney was again greater in DA rats and the ratio of Lewis/DA was 
least after the smallest dose. The amount found in the non perfused 
right kidney was minimal indicating that there was no systemic spillover
of Ig G t
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FIG 13 IgG+ content (in Jig/g of kidney ± SD) of kidneys of 
Lewis and DA rats at various times following IV bolus 
of Img XgG+. n = number of experiments at each time. 
The differences between the strains were significant 
p-<0.025 at all times using a student t-test.
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FIG 1 4 Uptake of IgG^ (in /Ig/g of kidney ± SD) by the kidneys 
of Lewis and DA rats at various times following an 
IV bolus of IgG^ Img. Each value is the mean of 
4 experiments. The differences were significant at each 
time point p<[0.025 using a student t-test.
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FIG 15 The specific uptake of IgG+ due to its charge
ie IgG+-IgG was greater in DA rats at all times 
up to 6 but not including 24 hours. Results 
expressed as /Ag/g of renal tissue.
T A B L E  6
EFFECT OF DOSE ON RENAL UPTAKE
DOSE OF IgG'*' NO LEWIS DA LEWIS/DA %
0.25mg 3 1.9 3.8 50.0
1.0 mg 5 11.6 17.8 64.9
5.0 mg 4 43.5 61.4 70.8
Effect of dose on renal uptake of IgG one hour eifter an 
IV bolus. Results expressed as jtlg/g of renal tissue, 
(mean value of number of experiments indicated.)
T A B L E T
RENAL ARTERY PERFUSION OF IgG
IgG* injected No
LEWIS
L R
DA
L R
LEWIS/DA % 
(L kidneys)
5 /ig 3 0.05 0.01 0.16 0.02 31.2
50 /ig 3 2.9 0.06 8.2 0.06 35.4
200 jUg 3 24.1 0.06 47.2 0.06 51.0
FIG Renal uptake of IgG following perfusion of left kidney. 
Results expresed as jUg IgG /g of kidney are the mean 
of the number of experiments indicated.
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3:1 :4 Renal uptake of IgG* in female rats
The difference in uptake of IgG* between sexes of the 2 strains of rat 
was studied. The renal uptake of IgG* one hour and 3 hours after an 
TV bolus of Img IgG* is shown in Fig 16. The uptake was least in male 
Lewis rats. The differences between the sexes of DA rats or between 
females of the 2 strains were comparatively small.
3:1:5 Uptake of IgG* by other organs
The uptake of IgG* and IgG*^  in liver, spleen and kidney 15 minutes 
after an TV bolus of Img of the protein is shown in Table 8. This 
demonstrates the specific uptake of IgG (IgG* - IgG^) is greater in 
DA rats in all tissues studied and that it is relatively less in the 
kidney compared to the liver or spleen.
3:1 :6 Renal uptake of aggregated IgG
The MW of aggregated Igl by SDS electrophoresis was greater than 
1 X 10^ daltons. The renal uptake of aggregated IgG following boluses 
of Img and 5mg is shown in Figs 17 and 18 respectively. The renal 
uptake by Lewis rats was 65-70% of that of DA rats at all times but the 
rate of removal from the kidneys was similar in both strains.
Renal uptake of IgG* - sex difference
cn
L3a
3 0
LEWIS
DA25 -
20
15-
5-
M F FM F M FM
Ihr TIME 3hrs
FIGURE 1 6 Renal uptake of IgG+ at Ihr and 3hrs following 
an IV bolus of lgG+ Img by the kidneys of male 
and female Lewis and DA rats. The values 
(in fig IgG'^/g of kidney) are the mean of the 
number of experiments indicated.
T A B L E  8
UPTAKE OF IgG BY OTHER ORGANS
L E W I S D A
SPLEEN
IgG+ igo” DIFF IgG"*" IgG** DIFF
21.4 18.0 3.4 32.0 22.4 9.6
LIVER 33.3 15.6 17.7 52.8 19.9 32.9
KIDNEY 8.6 8.8 -0.2 19.2 13.9 5.3
+ NUptake of IgG and IgG in ^ g/g of organ 15 minutes after IV bolus
4- N +of IgG Img or IgG Img. Each value of IgG is a mean of
N5 experiments and each value of IgG is a mean of 4 experiments.
CLEARANCE OF AGGREGATED IgG(lmg)16
14
12 Observed value
mean of observed values
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8
6
4
2
* D A  
t  LEWIS
24hr6321
FIG 1 7 The renal uptake of IgG (in /Ig/g of kidney) at various 
times following an IV bolus of Img agg IgG. Each value 
is the mean of 2 experiments as indicated.
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FIGURE 18 The renal uptake of agg IgG in (/Ag/g of 
kidney) by Lewis and DA rats at varying 
times. Each point is the mean of 
2 experiments.
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SECTION 2
3:2:1 Glomerular localisation of antigens by immunofluorescence
(a) IgG IF studies showed that at 15 minutes IgG"^  could be
detected along the GBM. As expected, it was present in greater 
amounts in DA rats. At 1 hour, IgG*** was detected both on the 
capillary loops and in the mesangium. By 3 hours it could be 
detected only weakly in the mesangium of DA rats and not at all 
in the Lewis rats. No extra glomerular IgG"*" was detected. Figs 
19 and 20 show the staining of FITC anti human IgG at 15 
minutes. Table 9 shows a summary of glomerular localisation 
following IgG*^ .
(b) IgG^ - IgG^ could not be detected by routine IF techniques 
although whole kidney counts showed it to be present. The 
procedure was repeated but without washing the slides prior to 
fixing and adding anti human IgG. Thereafter, weak mesangial 
staining of IgG*^  was found in both strains (Fig 22). It was 
concluded that IgG^ was present in the mesangium but was easily 
removed because it was unbound.
(c) Aggregated IgG - Deposits of aggregated Igl were detected in the 
capillary loop and mesangium at 15 and thereafter only mesangium 
at 1 hour (Fig 21 ).
T A B L E  9
GLOMERULAR LOCALISATION OF Ig(f FOLLOWING IV BOLUS IgG^ Img.
T I M E L E W I S D A
15 minutes ++ +++
cap loop cap loop
1 hour + ++
cap loop and mesangial cap loop and mesangial
3 hours +
mesangial
FIG 19 - GLOMERULAR IMMUNOFLUORESCENCE PATTERN OF
CATIONIC IgG AT 15 MINUTES IN THE LEWIS STRAIN
(x350)
FIG 20 - GLOMERULAR IMMUNOFLUORESCENCE PATTERN OF
CATIONIC IgG AT 15 MINUTES IN THE DA STRAIN
(x350)
amia
% #
n
«
Fig22
FIG 21 - GLOMERULAR IMMUNOFLUORESCENCE PATTERN OF
AGGREGATED IgG IN THE LEWIS STRAIN AT 1 HOUR
(x350)
FIG 22 - GLOMERULAR IMMUNOFLUORESCENCE PATTERN OF
NATIVE IgG AT 15 MINUTES IN THE LEWIS STRAIN
(x350)
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SECTION 3
3:3:1 Changes in glomerular permeability
The urinary excretion of HSA^ after a bolus of 5mg of IgG'*’ can be 
seen in Table 10. The mean urinary loss of HSA^ in Lewis rats was 
60.2jLlg whereas in DA rats it was I6.2jug. The urine excretion of HSA^ 
only (ie. without IgG”^) can be seen in Table 11 . The mean urinary 
loss in Lewis and DA rats was 9.65 and 5.48 jUg/24 hours respectively.
The second way of assessing glomerular permeability was to measure 
increased renal uptake of HSA resulting from a bolus of IgG"^ .
Table 12 shows that although the specific uptake of Igp"^
(IgG”^ - IgG^) was less in Lewis rats, the increase in uptake of HSA 
(HSA^ - HSAg) was greater at all times from 1 hour. No increase 
could be detected in either strain at 15 minutes and the increase in DA 
rats was only marginal at all times.
CHANGES IN GLOMERULAR PERMEABILITY
T A B L E  10
STRAIN NO
131
E X C R E T I O N  I -HSA
MEAN 
(jlAg/24 hrs)
RANGE 
(jUg/24 hrs)
SEM 
(jUg/24 hrs)
LEWIS 6 60.0 28 - 104 12.7
DA 6 16.2 10.4 - 20.4 2.0
131Urine excretion (/Ag/24 hrs) of I - HSA following
IV boluses of 5mg I^^^- HSA and 5mg IgG^ in DA and Lewis rats
Difference significant (p<[0.025) student t—test.
T A B L E  11
NO
HSA
MEAN 
pg/24 hrs
RANGE 
pg/24 hrs
LEWIS 3 9.65 3.56 -13.8
DA 3 5.48 1.83 - 8.81
131Urine excretion (jUg/24 hrs) of I HSA 
only in DA and Lewis rats.
T A B L E  12
EFFECT OF IgG (Img) ON RENAL UPTAKE OF HSA
TIME
L E W I S D A
+ N
IgG —IgG HSAc HSAs DIFF
IgC^-IgO^ HSAc HSAs DIFF
15 mins -0.26 4.5 3.5 1.0 5.3 11.7 11.9 -0.2
1 hr 1.3 10.2 3.5 6.7 4.0 12.5 11.9 0.6
3 hrs 0.1 8.8 3.5 5.3 4.1 13.2 11.9 1.3
6 hrs -0.3 11.2 3.5 7.7 1.9 14.4 11.9 2.5
24 hrs -1.2 10.7 3.5 7.2 -3.4 13.5 11.9 1.6
HSA Renal uptake of HSA given 15 min before death but after IgG Img 
given at times indicated.
HSAg = Renal uptake of HSA given 15 min before death but with no prior 
IgG+.
DIFF HSA - HSA c s
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SECTION 4
3:4:1 Binding of alcian blue to red cells of DA and Lewis rats
The alcian blue binding by red cells of Lewis and DA rats is shown in 
Fig 23. There was significantly less binding to the red cells of Lewis 
rats at concentrations of alcian blue of 125/ig/ml and 250fig/ml (p< 0.05 
using student t-test) but not 62.5jug/ral.
3:4:2 Competitive inhibition of alcian blue binding by polycations
The addition of the polycations hexdimethrine or protamine sulphate 
produced a dose dependent inhibition of AB binding (Fig 24). The 
concentration of alcian blue used in these experiments was 125^g/ml. 
There was little displacement of AB binding below this concentration for 
either or protamine sulphate.
3:4:3 Alcian blue binding to red cells of various glomerulopathies
Studies of AB binding to the red cells (ng AB per 10^ RBC) of patients 
with three different nephropathies and a control group is shown in Figs 
25 and 26. All values for the patients fell within the range of 
controls. Patients with IgAN had significantly greater binding than 
did patients with MCN or IMN whether the final concentration of AB was 
125jUg/ml or 250/ig/ml. There was no difference between the groups when 
the concentration of AB was 62.5jL4g/ml. The statistical values of these 
differences is shown in Table 13.
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FIG 26 Binding of Alcian blue (250jLlg) to red cells of normal 
controls or patients with either mesangial IgA, 
minimal change (MCN) or membranous nephropathy (IMN). 
Means are indicated by horizontal lines.
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CHAPTER 4 
SECTION I
SOME CONSEQUENCES OF VARIATION IN GLOMERULAR PROPERTIES INVESTIGATED 
BY ANIMAL MODELS OF GLOMERULAR INJURY
4:1:1 Heymann nephritis model (autologus immune complex nephropathy)
Proteinuria was detected in Lewis rats from 12 weeks onward but not DA 
rats (Fig 27). Control rats from both strains did not develop 
proteinuria.
Electron micrographs of the sections of the glomeruli of Lewis and DA 
rats are shown in Figs 28 and 29 respectively. Subepithelial deposits 
characteristic of Heymann nephritis were detected in Lewis but not DA 
rats.
4:1:2 Chronic serum sickness
Alternate day injections of cationic HSA produced no proteinuria in 
either of the 2 strains of rat over a 21 day period. Immunofluorescent 
studies of sections of kidney cortex showed deposits of rat IgG in both 
strains of rat. The deposits were less dense in Lewis rats and were 
found mainly on the capillary loop (Fig 31). No deposits were found in 
Lewis control kidneys (Fig 30) DA rats on the other hand, had dense 
mesangial deposits of rat IgG in both control and experimental kidneys 
(Figs 32 and 33). HSA could not be detected in kidneys of either strain 
by immunofluorescent techniques.
HEYMANN, NEPHROPATHY
250 - I LEWIS RAT (4)
DA RAT (4)
200 - LEWIS RAT CONTROL (4)
DA RAT CONTROL (4)
^ 150 -
g 100 -
50 -
e#v
21 3 54 6 7
MONTHS
FIG27 Urine protein excretion (mg/24 hours) in Lewis 
and DA rats after intradermal injection of 
12.5mg tubular antigen. Each point is the mean 
of 4 experiments.
FIG 28 - ELECTRONMICROGRAPH OF LEWIS RAT GLOMERULUS 7 MONTHS 
AFTER INJECTION OF TUBULAR ANTIGEN (FXIA).
(xl5500)
FIG 29 - ELECTRONMICROGRAPH OF DA RAT GLOMERULUS 7 MONTHS 
AFTER INJECTION OF TUBULAR ANTIGEN (FXIA).
(xl5500)
A
FIG 30 - GLOMERULAR IMMUNOFLUORESCENT PATTERN OF 
CONTROL LEWIS RAT KIDNEY. (x350)
FIG 31 - GLOMERULAR IMMUNOFLUORESCENT PATTERN OF 
LEWIS RAT KIDNEY AFTER INJECTION OF 
CATIONIC HSA. (x350)
Figé!
s
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4:1:3 Infusion of hexadimethrine (HDM)
Urine protein excretion in both strains was similar during the period 
of saline infusion. It remained unchanged in DA rats. Forty minutes 
after the start of the infusion of HEM, the urine protein 
loss of Lewis rats increased sharply and continued to increase until the 
end of the infusion when it quickly returned to basal values (Fig 34). 
Both strains of rat started to become oliguric towards the end of the 
saline infusion causing urine volumes to tail off.
4:1:4 Intravenous injection of puromycin aminonucleoside
A -single intra peritoneal injection of 16mg of Puromycin aminonucleoside 
produced proteinuria in both strains of rat by day 5. Fig 35 shows the 
mean protein excretion of the rats. This was'measured on alternate days 
for 3 days before the intraperitoneal injection and every alternate day 
thereafter for 21 days. Proteinuria was twice as much in DA rats 
compared to that of Lewis rats.
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FIG 34 Urine protein excretion (jXg/lO minutes) of DA and 
Lewis rats before, during and after an infusion of 
hexadimethrine. Each point is the mean and standard 
error of the mean of 6 experiments unless indicated.
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FIG 35 Urine protein excretion (mg/24 hours) of DA
and Lewis rats after an intraperitoneal injection 
of P A . The number in each group is indicated 
along the top of the graph. Each point is the 
mean ± SD.* p<0.05 using student t-test.
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CHAPTER 4 
SECTION 2
MODULATION OF THE GLOMERULAR DEPOSITION OF ANTIGEN BY FATTY ACIDS 
AND PROSTANOIDS
4:2:1 Release of PGI^ from rat aortas
The release of PGI^ from two sets of aortas, three rats in each group 
in each experiment can be seen in Figs 36 and 37- Both experiments 
showed that there was a greater release from Lewis aortic rings compared 
to DA aortic rings. Exhaustion times are different in the two sets of 
experiments. This was probably due to fluctuations in room or buffer 
temperatures therefore causing a faster rate of exhaustion.
4:2:2 Renal uptake of cationic I ^  by Lewis and DA rats on a 
fatty acid diet
Lewis and DA rats were fed on one of five different diets for six weeks 
as described in the methods section 6. The renal uptake of cationic IgG 
was measured and the results shown in Fig 38. The shaded areas 
represent the uptake of cationic IgC while on a normal laboratory diet 
mean + 2SD as established earlier (Fig 13).
Arachidonic acid enriched diets, caused a slight increase in renal 
uptake of cationic IgG in Lewis rats and a marked decrease in DA rats. 
Evening primrose oil caused an increase in uptake in Lewis rats but no 
change in DA rats.
The renal deposition of cationic IgG was determined by 
immunofluorescence and changes in deposition of rat IgG was also 
examined (table 14). The FITC anti human IgG was diluted 1:4 with
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distilled water. At this concentration no deposits of cationic IgG 
could be detected in the kidneys of either DA or Lewis rats fed on a 
normal diet. However using a straight dilution of the antisera 
mesangial deposits were detected (Figs 41 a and 41 b). Quite dense 
deposits of cationic IgG were found in the glomeruli of rats fed on the 
arachidonic acid enriched diet (Figs 39a and 39b). They were more 
apparent in DA than Lewis rats. Similar, but less marked deposits, were 
found in the kidneys of rats fed on other diets (Figs 40a and 40b) and 
were least in the rats fed on eicosapentanoic acid enriched diets.
Not only was the glomerular deposition of human cationized IgG 
increased, despite the changes found in the whole kidney, but increased 
deposits of rat IgQ were also found (table 14). There was close 
symmetry in the pattern of deposition in the two strains which were 
mostly mesangial with some capillary loop.
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FIG 36 PGIg release from aortic rings 
a mean of 3 experiments.
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FIG 39a - GLOMERULAR IMMUNOFLUORESCENCE PATTERN AFTER
STAINING WITH FLUORESCEINATED ANTIBODY TO HUMAN 
IgG (FITC anti human IgG) IN THE LEWIS STRAIN 
FED AN ENRICHED SAFFLOWER OIL DIET. (x350)
FIG 39b - GLOMERULAR IMMUNOFLUORESCENCE PATTERN AFTER
STAINING WITH FITC ANTI HUMAN IgG IN THE DA
STRAIN FED A SAFFLOWER OIL DIET. (x350)
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FIG 40a - GLOMERULAR IMMUNOFLUORESCENCE PATTERN
AFTER STAINING WITH FITC ANTI HUMAN IgG 
IN THE LEWIS STRAIN FED AN ENRICHED 
EVENING PRIMROSE OIL DIET. (x350)
FIG 40b - GLOMERULAR IMMUNOFLUORESCENCE PATTERN
AFTER STAINING WITH FITC ANTI HUMAN IgG 
IN THE DA STRAIN FED AN ENRICHED 
EVENING PRIMROSE OIL DIET. (x350)
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FIG 41a - GLOMERULAR IMMUNOFLUORESCENCE PATTERN AFTER 
STAINING WITH FITC ANTI HUMAN IgG IN THE 
LEWIS STRAIN FED A NORMAL DIET. (x350)
FIG 41b - GLOMERULAR IMMUNOFLUORESCENCE PATTERN AFTER
STAINING WITH FITC ANTI HUMAN IgG IN THE
DA STRAIN FED A NORMAL DIET. (x350)
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4:2:3 Renal infusions of PGE^ and PGI^
Infusion of PGE^ and PGI^ by the protocol described previously did 
not change renal uptake of cationic Igl in Lewis rats but considerably 
decreased it in DA rats to approximately the same quantity as was 
found in Lewis rats (table 15). Blood pressure remained steady at 
120 mmHg during both infusions in the 2 strains of rats.
The distribution of IgG*^  following PGE^ or PGI^ infusion is 
shown in Table 16. Glomerular immunofluorescence patterns of IgG"^  
are shown in Figs 42 and 44, and Figs 43 and 45 following PGE^ and 
PGI^ infusions respectively.
RENAL UPTAKE OF CATIONIC IgG AFTER INFUSION OF PGE^ or PGIq
T A B L E  15
INFUSATE
L E W I S D A LEWIS DA
MEAN
jUg IgG^/ g KIDNEY RANGE
GLYCINE
BUFFER 13.1 20.0 8‘51 - 13*67 19*5-23-3
PGIg 11 .1 13.2 7 80 - 12-96 10*4-14* 8
PGE^ 12.07 14.6 10-81 -13-70 12-88-1 5-80
Each value is the mean of 4 experiments
GLOMERULAR LOCALISATION OF HUMAN IgG AND RAT IgG 
AFTER PGE^ OR PG3^ INFUSION
I F STUDIES
TABLE 16
INFUSATE
L E W I S D A
ANTI HUMAN ANTI RAT 
IgG IgG
ANTI HUMAN ANTI RAT 
IgG IgG
Buffer wesik mes —Ve weak mes + mes
PGIg + mes 
+ cl
-ve + mes + mes
PGE^ + mes -ve + mes + mes
mes = mesangial
FIG 42 - GLOMERULAR IMUNOFLUORESCENCE PATTERN OF 
HUMAN IgG IN THE LEWIS STRAIN AFTER 
INFUSION OF PGE, . (x350)
FIG 43 - GLOMERULAR IMMUNOFLUORESCENCE PATTERN OF
HUMAN IgG IN THE LEWIS STRAIN AFTER
INFUSION OF PGI_. (x350)
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FIG 44 - GLOMERULAR IMMUNOFLUORESCENCE PATTERN OF 
HUMAN IgG IN THE DA STRAIN AFTER INFUSION 
OF PGE . (x350)
FIG 45 - GLOMERULAR IMMUNOFLUORESCENCE PATTERN OF 
HUMAN IgG IN THE DA STRAIN AFTER INFUSION 
OF PGI . (x350)
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CHAPTER 5 
SECTION 5:1:1
Variations in glomerular properties
This study was designed to define genetically controlled differences 
in two glomerular properties which may influence the uptake of antigen 
and thereby affect an individual’s susceptibility to some forms of 
glomerulonephritis.
Glomerulonephritis affects only a minority of people exposed to a 
particular cause such as endocarditis or penicillamine. The reasons 
why some individuals are susceptible are unknown. A strong inherited 
predisposition may be inferred by the close association with DR2 with 
Goodpasture’s syndrome (152), DR 3 with membranous nephropathy in 
European patients (153) and DR4 with mesangial IgA disease in Japanese 
patients (154). Two strains of healthy male rats, Lewis and DA, were 
studied because the former is susceptible to Heymann nephritis and the 
latter is resistant, an observation which we have confirmed.
Cationic IgG and aggregated IgG were used as probe antigens because 
their deposition within the glomerulus has already been studied and 
is thought to depend on charge and mesangial uptake respectively 
(103,42). Cationic IgG was used to make a quantitative assessment of 
the fixed negative charge carried by glycoaminoglycans on the 
glomerular capillary wall. This charge is crucial in maintaining the 
impermeability of the glomerular basement membrane (GBM) to negatively 
charged molecules of the size of albumin (155) and to prevent clogging 
of the filtering surface by large negatively charged molecules (43).
It is lost, or reduced, in most animal (156,157) and human 
nephropathies (158) associated with proteinuria and infusion of a 
polycation into the renal artery has been shown to cause proteinuria .
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Therefore, inherited differences in the quantity of negative charges 
on the glomerular capillary wall may be an important determinant of 
the renal response to disease.
The renal uptake of cationic IgG by Lewis rats was significantly less 
than the renal uptake by DA rats at all times from 15 minutes to 24 
hours (Fig 13)- Native Igl (IgG^) was used as a non-specific marker 
to eliminate differences in renal blood flow to or within the kidney 
between the strains so that the difference in uptake of Igl"^  and 
IgG^ is due to charge alone. Although the IgG*^  uptake was also 
greater in DA rats, the difference (IgG"^  - IgG^) confirmed that 
the specific uptake of IgG"*", due to its charge,was greater in DA 
rats. The specific uptake in Lewis rats was negligible as determined 
by this technique. However, this value may be falsely low as the 
clearance of IgG"*" due to charge on red cells and vascular 
endothelium was greater than that of IgG^. The difference in renal 
uptake of IgG^ between strains, could be due to an increased uptake 
of IgG*^  by the mesangium of DA rats. Previous studies have shown 
that cationic IgG deposits principally in the GBM (103). This was 
confirmed by immunofluorescent studies which showed a weaker GBM 
uptake in Lewis compared to DA rats. However, glomeruli were not 
separated to quantify precise differences.
Infusions of IgG"^  directly into the renal arteries of temporarily 
isolated left kidneys confirmed the difference between strains and 
showed that it was not due to a differential uptake of IgG^ by 
other tissues. In fact, the specific uptake of IgG"*" by liver and 
spleen was also greater in DA rats, which implies that other cell 
surfaces of DA rats possess greater numbers of negatively charged 
glycoproteins. It is interesting that the difference was 
proportionally greater when the lowest dose of antigen (IgG"*") was 
used, whether given intravenously or into the renal artery.
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Since antigen probably circulates in very low concentrations in 
clinical states, this observation may account for variation and 
susceptibility to some nephropathies. Another finding of clinical 
interest is that the charge on the GBM of male Lewis rats was less 
than that of female. The difference between sexes was not so marked 
for DA rats. Lewis rats are susceptible to Heymann nephritis of which 
membranous nephropathy is the equivalent in man which has a distinct 
male preponderance - as high as 5.3:1 in patients of Glasgow Royal 
Infirmary (154). However, it is not clear how, or if, a reduced 
charge predisposes to membranous nephropathy.
The second glomerular property examined in this study was the renal 
uptake of aggregated IgG. Previous studies have shown that a small 
proportion of intravenously administered aggregated IgG is deposited 
in the mesangium and this has been used as a test of mesangial uptake 
(42). Large molecules such as aggregated IgG enter the mesangium, 
through that part of the capillary where endothelial cells are in 
direct contact with mesangial cells or matrix because the GBM, which 
surrounds the rest of the capillary, is reflected onto adjacent 
capillaries (Fig 4). Studies using tracer molecules such as imposil 
have shown that mesangial traffic passes down the mesangial stalk to 
the hilum of the glomerulus. Thereafter, its route is unknown; it may 
enter the distal tubule, the distal arteriole, or more likely the 
renal lymphatic system. Alternatively, it may be degraded in the 
mesangium itself (160). One of the main functions of the mesangium is 
to remove debris from the capillary walls (43), as was shown by the 
removal of both IgG"*" and aggregated IgG from the capillary loops 
into the mesangium in the immunofluorescent studies. It is 
interesting that IgG"*" which is apparently bound to fixed negative
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charges in the GBM is transferred to the mesangium at the same rate, 
as aggregated IgG (at least within the experimental limitations of 
this study). The reasons for this are not clear. The rate at which 
antigen is transferred from the capillary loop into the mesangium may 
be slowed by antibody binding to it while it is on the capillary wall 
(104). Therefore, slow transfer is more likely to lead to membranous 
deposits and quick transfer to mesangial deposits.
Whole kidney uptake of aggregated Igl was greater in DA than Lewis 
rats but the relative difference was not dose dependant (Figs 17 and 
18). Immunofluorescent studies showed that aggregated IgG was on the 
GBM at 15 minutes and in the mesangium at 1 hour and was denser in the 
DA rat. It is probable that the increase in mesangial uptake of 
IgG^ seen in DA rats was also due to an increased mesangial uptake 
in that strain. However, it proved difficult to identify it by 
immunofluorescent studies presumably because it was not bound and was 
easily washed off. Traces of IgG*^  were found in the mesangium when 
the slides were not washed before fixing.
Therefore, it has been shown that the glomeruli of healthy male Lewis 
and DA rats differ in that Lewis rats have a reduced functional 
glomerular capillary loop charge and a lesser mesangial uptake under 
basal conditions. However, the studies have not shown whether these 
properties are separate or interdependant. Nonetheless, these 
differences may be important factors in determining the susceptibility 
of the 2 strains of rat to various forms of glomerular injury.
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CHAPTER 5 
SECTION 5:1:2
Consequences of variations in glomerular properties in response to 
animal models of glomerular injury
The significance of the difference in glomerular properties between 
the two strains was examined by comparing their response to four 
models of glomerular injury. These were:
(a) Heymann nephropathy in order to confirm the reason for the
original choice of the 2 strains.
(b) Chronic serum sickness induced by cationic HSA.
(c) Infusion of hexadimethrine (RDM) into the renal artery.
(d) Puromycin aminonucleoside nephropathy (PAN)
Heymann nephritis (Autologous immune complex nephritis)
The two strains were chosen because Lewis rats are susceptible to 
Heymann nephritis (HN) and DA rats are not. Other work has shown that 
strains of rats which are susceptible to HN share a particular MHC 
gene. It was shown that the Lewis rat carried the (H - 1 ) 
histocompatibility haplotype and were highly susceptible, whereas DA 
rats which carried the (H - I^) were resistant. Strains which 
shared the Lewis strain genetic background (H - 1 ) were weakly 
susceptible to HN (I6l).
Heymann nephritis is the animal model of idiopathic membranous 
nephropathy and is characterised by subepithelial immune complexes 
made up of antigen, and autologous antibody to it (97,99).
Characterisation of the antigen from brush border membranes of renal 
tubules showed that it consisted of a large glycoprotein that had a 
molecular weight of approximately 600,000 and was highly nephritogenic 
for the induction of HN (100).
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It is thought that this antigen may be a constituent part of the 
epithelial cell membrane, however this remains controversial. Using 
the passive Heymann nephritis model (PHN), immune complexes were 
detected in the kidney after perfusion of antibody into the renal 
artery of an isolated kidney. As a single by-pass system was used to 
prevent the possibility of deposition of circulating immune complexes, 
it was hypothesised that the immune complexes were formed in situ with 
the antigen being an intrinsic part of the GBM (98). On the other 
hand it is possible that the antigen circulates in very low 
concentration and may be deposited in that site because of its 
physical properties. If the properties of the kidney are altered by 
infusion of puromycin aminonucleoside (PA) into one renal artery in 
such a way as to prevent systemic spillover, and the rat is then 
immunised with FX1A; then the complexes form in the mesangium, until 
the proteinuria induced by PAN disappears and thereafter the complexes 
are formed in the capillary loop. The unperfused kidney develops 
membranous complexes. Thus, this experimental data suggests that it 
is unlikely that the antigen is a constituent part of the epithelial 
cell membrane and altering the glomerular properties changes the site 
of antigen deposition (162).
The results shown in fig 27 are characteristic of active Heymann 
nephropathy. Proteinuria developed in Lewis rats 12 weeks after 
immunisation and when the animals were sacrificed at 30 weeks dense 
deposits, typical of immune complexes, were found in the epithelial 
side of the capillary loop. No proteinuria and no deposits were found 
in DA rats.
The difference in susceptibility of the two strains may occur for 
several reasons. The antigen may be absent in DA rats, or they may 
remain tolerant to it. It is also possible that the complexes do form 
but are removed because of the difference of glomerular properties.
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This was not explored further, but instead other animal nephropathies 
were examined.
Chronic serum sickness
A model of chronic serum sickness described by Border et al (103) 
who demonstrated that repeated immunisation with cationic BSA caused a 
membranous nephropathy in rabbits, whereas native BSA led to the 
deposition or formation of mesangial immune complexes, was used. They 
had previously performed the same experiments in Sprague-Dawley rats, 
all of which developed a mesangial nephropathy whether the antigen was 
cationic or not (124). They hypothesised that the cationic charge of 
the antigen was important in its binding to the glomerular basement 
membrane. Cite reported that antibody fixing to antigen on the GBM 
delayed its transfer into the mesangium (104). Therefore, if Border's 
hypothesis that charge is an important factor in localising the 
antigen is correct, then the DA strain having the greater charge on 
the GBM should develop capillary loop deposits when challenged with a 
cationic antigen. But, if the rate of transfer from the capillary 
loop to the mesangium is more important and if this is a function of 
mesangial uptake, then the DA strain should develop mesangial lesions. 
In the event, Lewis rats with a lower charge and lesser mesangial 
uptake of cationic 1 ^  developed membranous lesions and DA rats with 
a greater charge and greater mesangial uptake had mesangial lesions.
It is of interest that similar mesangial deposits of IgG were found in 
all control DA rats. No deposits of HSA could be detected by 
immunofluorescence in either strain. This experiment suggests that 
the rate of transfer to the mesangium is important in determining the 
site at which complexes form.
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Infusion of hexadimethrine
In order to test the significance of the reduction in negatively 
charged sites on the GBM of Lewis rats a polycation was infused 
intravenously. Hunsicker et al had shown the intravenous infusion of 
Hexadimethrine into rats caused fusion of epithelial foot processes 
and proteinuria and attributed this to masking of the glomerular 
polyanion (117).
Intravenous infusions of hexadimethrine caused proteinuria in Lewis 
but not DA rats confirming the significance of the the reduction in 
negative charge in the Lewis rat. Therefore, Lewis rats are more 
likely to develop proteinuria as a result of any mechanism which leads 
to the abolition or masking of charge.
This hypothesis was supported by the finding that intravenous 
injection of cationic IgG caused a greater loss of radiolabelled HSA 
into the urine in Lewis compared to DA rats (table 10). In order to 
assess how quickly this change in glomerular permeability occurred,
HSA^ was given 15 minutes before sacrifice and the renal uptake of 
HSA (HSA^) measured. The increase in uptake of HSA^ following 
IgG"^  given at various times before sacrifice (HSA^- HSA^) is an 
index of glomerular capillary permeability. The results (table 12) 
showed that an increase in uptake of HSA^ did not occur at 15 
minutes, but had occurred by 1 hour in Lewis rats and persisted for 24 
hours. No increase in uptake of HSA occurred in DA rats until three 
hours and even then it was minimal. It is interesting to note the 
time similarity between this experiment and the HDM infusion in which 
proteinuria started 40 minutes after the start of the infusion.
However, in the former case it was not proven that increase in HSA 
uptake by the kidney was due to HSA crossing of the GBM, but no other 
explanation seems probable.
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These three experimental models which either caused proteinuria or 
increased uptake of HSA after infusion of a cation, again suggests 
that a decreased charge on the GBM of Lewis rats is of biological 
importance in disease,
•v:
Infusion of puromycin aminonucleoside (PA)
The final animal model studied was that of puromycin aminonucleoside 
nephrosis of which the pathogenesis is not understood. Experimental 
evidence has shown that PAN causes proteinuria in rats by a direct 
effect on the kidney and takes five days to do so; therefore, 
suggesting that it is not a direct effect on the charge, but more 
likely a change in the metabolism of the glomerulus, perhaps by 
causing a decreased production in glycoaminoglycans or production of a 
local proteinuric factor. Proteinuria was transferred by 
transplantation of the kidney from rats with established proteinuria, 
to normal rats which had not received puromycin aminonucleoside thus 
confirming that this substance has a direct effect on the kidneys and 
does not involve systemic factors (163).
DA rats developed twice as much proteinuria compared to Lewis rats 
(Fig 35). Previous experiments have shown that DA rats have an 
increased mesangial uptake of circulating proteins and other molecules 
compared with Lewis rats and this may be the reason for the increased 
proteinuria in DA rats. An increased uptake of PA by mesangial cells 
would lead to a greater dose of PA per glomerulus and greater 
proteinuria. Since the actual mechanism of PAN is not known the 
significance of these experiments is difficult to interpret. However, 
it is interesting that there is a variation of such magnitude between 
the two strains.
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SECTION 5:1:3
CLINICAL APPLICATION OF ANIMAL STUDIES
Variation in charge on red cells in patients 
subject to various human glomerulopathies
In this study, quantitative analysis examination of the negative 
charge on the surface of red cells was undertaken in three groups of 
patients, while their nephropathy was in complete or partial remission 
Previous studies had shown a correlation between the red cell charge 
and the charge of the glomerular capillary wall (COW) in the two 
strains of rat. The glomerular polyanion maintains the impermeability 
of the GCW to negatively charged molecules the size of albumin and it 
is reduced in almost all animal and human nephropathies associated 
with proteinuria. The red cell charge may be reduced by the same 
processes which lead to loss of glomerular polyanion, as was shown by 
Levin, who demonstrated a reduction in children during the nephrotic 
phase of minimal change nephropathy. To determine the charge 
unaffected by the disease process, patients were studied when in 
complete or partial remission as defined by a 24 hour urine protein 
excretion of less than 2.2g. The results showed that there was a 
significant difference in the surface charge of red cells of patients 
with IgAN compared with that of red cells of patients with MCN or IMN. 
The values for the three patient groups all fell within the normal 
control range. These results provide indirect evidence for a 
similarity between the kidneys of patients with IMN and Lewis rats. 
Both have a lower red cell charge than patients with IgAN or DA rats 
respectively; both are liable to form capillary loop immune complexes 
and to develop heavy proteinuria. Therefore, it is probable that 
patients with IMN and MCN have a lesser charge on their glomerular 
capillary wall than patients with IgAN and this is the probable cause
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of their susceptibility to proteinuria. The pathogenesis of 
proteinuria in MCN is thought to result from an electrochemical change 
of the glomerular cell wall perhaps caused by release of a factor 
which increases vascular permeability (164). Lymphocytes of patients 
with IgAN, release as much vascular permeability factor as do 
lymphocytes of patients with MCN, but proteinuria may be less because 
of denser polyanion on their glomerular cell wall. Another 
consequence of the difference in charge on cell and membrane surfaces 
may be at the site at which antigen deposits. The site at which 
antigen is fixed by antibody in the kidney has been shown to depend on 
the physical properties of the antigen. Equally important and not 
previously considered are the properties of the glomeruli themselves.
As previously discussed one antigen has been shown to cause membranous 
deposits in one kidney and mesangial deposits in the other if the 
properties of the latter have been changed by infusion of puromycin 
aminonucleoside (162).
The reason why Lewis rats are susceptible to membranous nephropathy 
remains unclear. Lewis rats differ from DA rats not only in the 
charge of their red blood cells and glomerular capillary wall but also 
in their mesangial uptake, which is the mechanism which maintains the 
glomerular barrier free of filtration residues. A reduced mesangial 
uptake, may delay the removal of antigen and thus lead to the 
formation of capillary loop immune complexes, whereas a greater 
mesangial uptake would lead to mesangial complex formation. This 
would imply a link between reduced charge and reduced mesangial 
uptake. If charge indirectly controls mesangial uptake, then 
modulations of mesangial uptake may offer a new approach to the 
therapy of these nephropathies.
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CHAPTER 5 
SECTION 5:1 :4
Modulation of glomerular properties by prostaglandins
Inherited glomerular properties have been shown to influence 
glomerular response to different injuries. Lewis rats, with a lower 
capillary wall charge and lower mesangial uptake, are prone to the 
formation of membranous immune complexes and heavy proteinuria. On the 
other hand DA rats are prone to mesangial complexes and resistant to 
the development of proteinuria. Differences in charge may not offer a 
therapeutic opportunity although mesangial uptake has been shown to 
vary. It is possible that a lower charge, if present on platelets and 
vascular endothelium, may predispose to more collisions between the 
two and thus cause release of more prostacyclin (PCI.) to prevent 
platelet aggregation and endothelial damage. This possibility was 
supported by the increased rate of release of PCI^ by aortic rings 
of normal Lewis rats compared with DA rats. It was proposed that 
increased release of PGI^ would lead to reduced mesangial uptake.
This hypothesis would associate low charge with reduced mesangial 
uptake. Mesangial uptake is increased in puromycin aminonucleoside 
nephrosis (PAN), nephrotoxic serum nephritis both of which are 
associated with loss of glomerular cell wall charge and by angiotensin 
II (147,165,174). Angiotensin II has been shown to increase mesangial 
uptake of an intravenously administered molecule, keyhole-limpet 
haemocyanin (78). All these factors also lead to mesangial cell 
contraction, which may be the mechanism by which mesangial cell uptake 
is increased. The measurements of mesangial uptake made in the study 
however, do not discriminate between rate of removal from the 
capillary loop into the mesangium and the rate of removal from the 
mesangium.
Human glomeruli synthetize mainly PCI^and also some TxB^, PCE^ and
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PGF^^(166,1 67)- On the other hand, the principal prostaglandin 
produced by the glomeruli of the Sprague Dawley rat is PGE^ (168). 
Human mesangial cells produce predominantly PGI^ in culture (169) 
similar to the isolated human glomerulus. The physiological 
significance of prostaglandins produced by the glomerulus is 
uncertain. One hypothesis is that they have an important role in 
autoregulation of renal blood flow and in compensatory mechanisms 
following renal damage. The effect on mesangial uptake is unknown but 
PGI^, PGE-f cause,, mesangial cell contraction through increased 
synthesis of angiotensin II (All)(170). Beierwaltes et al 
exposed cultures of isolated glomeruli to arachidonic acid enriched 
media and noted not only a marked increase in prostaglandin synthesis, 
but also a significant release of renin demonstrating a direct local 
prostaglandin-renin interaction within the glomerulus (171).
Therefore, an increase in glomerular prostaglandin production leads to 
an increase in angiotensin II synthesis, which in turn increases 
mesangial uptake perhaps by mesangial contraction. Infused 3H All 
localises primarily in the mesangial region of rat glomeruli, and 
specific receptors for All on mesangial cells have been identified 
(172). All causes contraction of cultured glomerular mesangial cells 
in vitro (173) and All infusion in vivo results in a lowering of the 
glomerular capillary ultrafilatration coefficient (174).
Prostaglandins have also been used in the treatment of some forms of 
glomerulonephritis. Administration of PGE^ has been shown to 
ameliorate the evolution of the nephropathies in NZB/W and MRL/1 mice. 
The mechanism by which this is achieved is unknown, but has been 
ascribed to the effect of PGE^ on the immune response (135). A 
thromboxane synthetase inhibitor was shown to greatly reduce the 
proteinuria caused by adriamycin (175). Recent reports have 
demonstrated beneficial effects of dietary polyunsaturated fatty acids
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on immune complex forms of glomerulonephritis. A menhaden oil diet, 
rich in eicosapentaenoic acid, protected female NZB/WF^ mice from 
autoimmune disease. Injections of pharmacological doses of 
prostaglandins have been shown to have beneficial effects in various 
models of renal disease. Intravenous infusion of PGE^ improved 
renal function in patients with chronic renal failure by increasing 
creatinine clearance by 29%. The benefit seem to have been sustained 
for 1.5-7 months after the course of the PGE^ infusions. There was 
no significant change in 24 hour urinary protein excretion. It was 
hypothesised that the improvement in renal function with PGE^ may be 
related to its vasodilatory action (176).
Studies were performed to examine the effect on renal uptake of 
cationic IgG either by direct infusion of PGI^ or PGE^ or by an 
enriched fatty acid diet. The rationale for using cationic Igl was 
that it had already been shown that it bound to the GBM at 15 minutes 
and by 1 hour had begun to move into the mesangium and its site of 
deposition could be assessed by immunofluorescence. Therefore, the 
renal uptake at 1 hour is a measure of mesangial uptake. For these 
reasons the rats were sacrificed at 1 hour after intravenous injection 
of cationic IgG to measure variation of mesangial uptake. The 
polyunsaturated fatty acids (PUFA) derivatives used in the study are 
precursors of oleic, linoleic and eicosapentaenoic acids, which in 
turn are precursors of the mono (177) di (178) and trienoic (179) 
prostaglandins respectively (Fig 46). Fig 38 shows the renal uptake 
of cationic IgG in rats fed on one of four fatty acids enriched diets.
Arachidonic acid caused a marked decrease in renal uptake in DA rats 
which remained unchanged in Lewis rats. This may be the result of the 
higher PGI^ production in normal Lewis rats. No consistent change 
of renal uptake occurred in either strain fed on the enriched EPA
diet
pyruvate 16:0 18:0
diet diet
19
16:1 (n-7) 
palmitoleic
18:1 (n-7)
69,6,5,4:
E: elongases
1 9
18:1 (n-9) 
oleic
16
18:2 (n-9) 
E
20:2 (n-9)
1 5
20:3 (n-9) 
mead
22:3 (n-9)
18:2 (n-6) 
linoleic
16
18:3 (n-6)
8 -  linolenic 
E
20:3 (n-6) 
dihomo- 8 -  
linolenic
I"'
20:4 (n-6) 
arachidonic
22:4 (n-6)
18:3 (n-3) 
a -linolenic
l6
18:4 (n-3) 
E
20:4 (n-3)
I s
20:5 (n-3) 
timnodonic
22:5 (n-3)
1 4
22:6 (n-3)
fatty acid family: (n-9) (n-6) (n-3)
FIG 46 - MAJOR BIOSYNTHETIC PATHWAYS OF FATTY ACIDS
99
diet. Diets enriched with EPO caused an increased renal uptake in 
Lewis rats but no change in DA rats. Direct infusion of PGI^ or 
PGE^  caused a decreased renal uptake in DA rats but no change in 
Lewis rats (ie) comparable to results with AA enriched diet 
(table 15) Interestingly, immunofluorescent studies showed that 
glomerular uptake, particularly mesangial uptake, increased with all 
diets and also PGE^ and PGI^ infusions. This discrepancy 
between total kidney uptake and increased glomerular uptake of 
cationic IgG is not understood. Infusion of PGE^ caused a marked 
increase in mesangial deposition of antigen, but following PGI^ 
infusion, IgG"*" was deposited both in the mesangium and around the 
capillary loops. This difference occurrred in both Lewis and DA rats. 
The role of the higher production of PGI^ by the vascular 
endothlelium of Lewis rats in their susceptibility to capillary loop 
immune complex formation has not yet been investigated further.
Prostaglandins including PGI^ and PGE^  , have been shown to enhance 
glomerular monocyclic nucleotide production (170) which in turn is 
capable of stimulating renin release and angiotensin II production 
which is known to increase mesangial uptake. Therefore, it seems 
likely that the increase in mesangial uptake is due to the ability of 
prostaglandins to stimulate local intrarenal angiotensin II production 
via the generation of cAMP and thus cause mesangial contraction. How 
and if mesangial contraction leads to increased mesangial uptake 
remains contoversial. Ward et al suggested that increased mesangial 
uptake may be due to an increased percolation of plasma through 
mesangial intercellular channels. Infusions of high doses of 
angiotensin II have been shown to enlarge the intercellular channels 
in the mesangium (180). This may be a direct effect of mesangial cell 
contraction. Whatever the mechanism, the results in this study show
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that infusion of prostaglandins clearly enhances mesangial 
localisation of antigen. It remains to be determined whether this 
result can be extrapolated to infer that kidneys subjected to the 
intraglomerular effects, that is increased mesangial uptake, might be 
prone to develop cumulative mesangial localisation of high molecular 
weight materials naturally present in the circulation as was seen in 
normal healthy DA rats. If so, the rate of progression of glomerular 
lesions in any of the human or animal diseases characterised by 
prominent mesangial accumulation of abnormal materials such as 
diabetic nephropathy, may be susceptible to modulation by angiotensin 
II, prostaglandins and their precursors or antagonists. Some support 
for this comes from the study by Hamazaki (I8l). Twenty patients with 
IgA nephropathy were divided into two groups, one group treated with 
fish oil (1.6g EPA) for one year and the other was not. After one 
year, renal function had not changed significantly in the EPA group, 
although, the controls had significantly deteriorated. It was 
hypothesised that EPA might be a safe and useful agent to stop the 
progression of IgA nephropathy. Prostanoids may, therefore, justify 
further investigation to evaluate their role in modulating mesangial 
flow.
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CONCLUSION
The results of the experiments described in this thesis would suggest 
a new hypothesis in the pathogenesis of immune complex 
glomerulonephritis. Earlier hypotheses had postulated that the 
kidney was an innocent victim due to the high hydrostatic pressure of 
its' capillary bed. Failure to eliminate antigen was an indication of 
immune deficiency which was thought to be a precondition for the 
persistence of circulating immune complexes. It was later shown that 
many forms of animal glomerulonephritis could be produced by in situ 
immune complex formation and that the site of deposition of the 
antigen depended on its' properties.
In this thesis it has been shown that glomeruli possess properties 
which vary between two strains of rat. These properties may account 
for differences in the expression of various forms of experimental 
glomerular injury. Low charge on the glomerular capillary wall was 
associated with low mesangial uptake and high charge associated with 
high mesangial uptake. Experiments have yet to be performed to see if 
there is a causal link between the two properties.
Mesangial uptake can be modulated by a variety of stimuli including 
the prostanoids, as was demonstrated in this thesis. Mesangial uptake 
is a result of movement of molecules into the mesangium from the 
capillary loop and degradation or. removal .from the mesangium. If the 
movement of complexes into the mesangium could be enhanced this might 
be of benefit to patients with capillary loop deposits. Similarly, if 
the removal of complexes from the mesangium could be accelerated, this 
may be useful in the treatment of patients with mesangial immune 
complex diseases. Indirect evidence that the differences found
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between Lewis and DA rats, may resemble those between patients with 
Idiopathic membranous nephropathy and IgA nephropathy (provided by the 
studies of the red blood cell membrane charges) suggests that such 
investigation would be relevant in man.
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APPENDIX
Buff ers
Standard dialysis buffer (working buffer)
17.55g Sodium chloride (NaCl)
0.40g Ethylene diaminetetra-acetic acid (EDTA) 
Made up to 2 litres with distilled water - pH 8.6
Buffer A - (protein modification buffer)
3-28g. di sodium hydrogen phosphate (Na^HPO^) 
8.77g Sodium chloride (NaCl)
Made up to 1 litre with distilled water - pH 5.5
Isoelectric focusing reagents
Fixing solution
5% Sulphosalicylic acid 
10% Trichloroacetic acid 
in distilled water.
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Destaining solution
35% Ethanol 
10% Acetic acid 
in distilled water.
Staining solution
0.2% cooraassie blue
disolved in destaining solution.
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PROTEIN ASSAYS
Urine total protein using the Rice method
Principle Protein is precipitated from urine with phosphotungstic 
acid and assayed using the Biuret reagent.
Sensitivity The limit of detection is 3mg/1 00ml and the standard 
curve is linear to 200rqg/1 00ml.
REAGENTS
Tsuchiya’s reagent
Biuret reagent
Blank reagent
To 365ml absolute alcohol in a 500ml 
beaker, add 10ml deionised water and 
25ml cone hydrochloric acid. Dissolve 
7.5g phosphotungstic acid in this 
solution.
1 .5g CuSOj^  5HpO (AR) are dissolved 
in approximately 500ml deionised water 
followed by 6.0g Sodium Potassium 
Tartrate (AR). Add with stirring 
30g NaOH (AR). Dilute to 1 litre.
As above omitting 1 .5g CuSO^ DH^O.
STANDARDS
Prepare standards 10-200mg/100ml using Human albumin fraction V (Miles 
laboratories) suitably diluted with 0.9% NaCL.
METHOD
Test the urine with Labstix and dilute as necessary with saline. 
Label pairs of conical centrifuge tubes for Test (T) and Blank (B). 
Pipette 2ml of urine samples and standards into appropriate pairs of
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tubes. Add 2ml Tsuchiya's reagent to all tubes with shaking, mix and 
incubate at 56 °C in water bath for 15 minutes. Centrifuge at 
2500rpm for 10 minutes and aspirate off supernatant. Add 1ml absolute 
ethanol to all tubes and mix on a whirlimixer. Centrifuge for 5 
minutes and remove supernatant. Wash again with 1ml ethanol and 
remove supernatant. To all tubes labelled ’T' add 4ml Biuret reagent 
and 4ml of blank reagent to all tubes labelled 'B1 Ensure all 
precipitate is dissolved by mixing on a whirlimixer. Leave for 30 
minutes for full colour development. Read absorbance at 540nm.
Blanks are read against Blank reagent and tests against Biuret 
reagent. Prepare a standard curve of corrected absorbance against 
concentration. Report results to 2 decimal places, ie g/vol.
LOWRY PROTEIN ASSAY
Principle
This method of protein assay combines the Biuret reaction and the 
Folin ciocalteu reaction. In the Biuret reaction, a solution of 
protein is treated with Cu^ ions in a moderately alkaline medium 
and a blue coloured chelate complex is formed between the Cu"*"*" ion 
and the carbonyl and imine groups of the peptid bonds. Folin 
ciocalteu reagent is used to measure phenolic compounds and to assay 
Tyrosine, which has a phenol side chain. This reagent oxidises the 
phenolic compounds, itself being reduced from yellow to blue.
The Lowry reaction is about 100 times as sensitive as the Biuret 
method, but a number of buffers containing amino groups, or 
substituted amino groups (eg TRIS, glycine amide), interfere by 
producing a colour.
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REAGENTS
Stock reagents
i) Solution A 2% Na^CO^ in 0.1 N NaOH
ii) Solution B 2% Na K Tartrate in deionized water
iii) Solution C 1% Cu SO^ i in deionized water
iv) Folin ciocalteu reagent.
Working reagents
i) Biuret reagent:- To lOOmls solution A, add 1ml
solution B and 1ml solution C. 
ii) Working Folin ciocalteu reagent:- dilute the stock
reagent 1 :1 with deionized water.
STANDARDS
i) Stock standard - Human serum albumin - 1 mg/ml.
Store at -15 °C.
ii) Working standards
A working standard curve in the range 0-1 OOug is prepared by 
taking 0, 50, 75 and lOOjUl of stock standard and adjusting 
the final volume to 400/il with deionized water as shown in 
Table 1 .
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TABLE 1
Volume of stock Volume of deionized H^O Final protein 
standard concentration
(mD (mD (jUg)
- 400
25 375 25
50 350 50
75 325 75
100 300 100
Sample preparation
Any sample requiring dilution should be diluted using deionized water 
and the final volume adjusted to 400ul.
Quality control
Bovine serum albumin, 0.6mg/ml. lOOul of the control is taken and the 
volume adjusted to 400jul with deionized water.
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Method
i) To 400/a1 of standard, control and sample, add 2mls Biuret
reagent.
ii) Vortex and stand for 10 minutes.
iii) Add 200jul of working folin ciocalteu reagent.
iv) Vortex and stand for 30 minutes.
v) Read CD at 750nm.
vi) Plot OD-cQ vs concentration of standards. Read unknowns
from the standard curve.
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